{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:49:50Z","timestamp":1790693390848,"version":"4.1.0"},"reference-count":356,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12035-015-9390-0","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T23:58:49Z","timestamp":1441756729000},"page":"4833-4864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Dissecting Complex and Multifactorial Nature of Alzheimer\u2019s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective"],"prefix":"10.1007","volume":"53","author":[{"given":"Puneet","family":"Talwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibha","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritushree","family":"Kukreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"key":"9390_CR1","unstructured":"WHO dementia fact sheet 2012 (last accessed 20.1.2015)\u2014 http:\/\/www.who.int\/mediacentre\/factsheets\/fs362\/en\/"},{"issue":"9064","key":"9390_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","volume":"349","author":"K Maurer","year":"1997","unstructured":"Maurer K, Volk S, Gerbaldo H (1997) Auguste D and Alzheimer\u2019s disease. Lancet 349(9064):1546\u20131549. doi: 10.1016\/S0140-6736(96)10203-8","journal-title":"Lancet"},{"issue":"1","key":"9390_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C et al (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8(1):1\u201313. doi: 10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"9390_CR4","unstructured":"Prince M, Albanese E, Guerchet M, Prina M (2014) The World Alzheimer Report 2014, dementia and risk reduction: an analysis of protective and modifiable factors"},{"issue":"3","key":"9390_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/NMD.0000000000000264","volume":"203","author":"G Cipriani","year":"2015","unstructured":"Cipriani G, Borin G, Del Debbio A, Di Fiorino M (2015) Personality and dementia. J Nerv Ment Dis 203(3):210\u2013214. doi: 10.1097\/NMD.0000000000000264","journal-title":"J Nerv Ment Dis"},{"issue":"9","key":"9390_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.biocel.2011.05.001","volume":"43","author":"MT Fodero-Tavoletti","year":"2011","unstructured":"Fodero-Tavoletti MT, Villemagne VL, Rowe CC, Masters CL, Barnham KJ, Cappai R (2011) Amyloid-beta: the seeds of darkness. Int J Biochem Cell Biol 43(9):1247\u20131251. doi: 10.1016\/j.biocel.2011.05.001","journal-title":"Int J Biochem Cell Biol"},{"issue":"9347","key":"9390_CR7","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/S0140-6736(02)11667-9","volume":"360","author":"K Ritchie","year":"2002","unstructured":"Ritchie K, Lovestone S (2002) The dementias. Lancet 360(9347):1759\u20131766. doi: 10.1016\/S0140-6736(02)11667-9","journal-title":"Lancet"},{"key":"9390_CR8","unstructured":"Strobel G. Early Onset Familial AD. What Is Early Onset Familial Alzheimer Disease (eFAD)? http:\/\/www.alzforum.org\/early-onset-familial-ad\/overview\/what-early-onset-familial-alzheimer-disease-efad"},{"issue":"3","key":"9390_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P et al (2014) Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83(3):253\u2013260. doi: 10.1212\/WNL.0000000000000596","journal-title":"Neurology"},{"issue":"Pt 7","key":"9390_CR10","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/brain\/awh501","volume":"128","author":"A Jimenez-Escrig","year":"2005","unstructured":"Jimenez-Escrig A, Gomez-Tortosa E, Baron M, Rabano A, Arcos-Burgos M, Palacios LG, Yusta A, Anta P et al (2005) A multigenerational pedigree of late-onset Alzheimer\u2019s disease implies new genetic causes. Brain 128(Pt 7):1707\u20131715. doi: 10.1093\/brain\/awh501","journal-title":"Brain"},{"issue":"1","key":"9390_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA et al (2011) Autosomal-dominant Alzheimers disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther 3(1):1. doi: 10.1186\/alzrt59","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"9390_CR12","first-page":"300","volume":"2","author":"PK Panegyres","year":"2013","unstructured":"Panegyres PK, Chen HY (2013) Differences between early and late onset Alzheimer\u2019s disease. Am J Neurodegener Dis 2(4):300\u2013306","journal-title":"Am J Neurodegener Dis"},{"issue":"3","key":"9390_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11882-013-0417-1","volume":"14","author":"BJ Balin","year":"2014","unstructured":"Balin BJ, Hudson AP (2014) Etiology and pathogenesis of late-onset Alzheimer\u2019s disease. Curr Allergy Asthma Rep 14(3):417. doi: 10.1007\/s11882-013-0417-1","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"9390_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn3271","volume":"13","author":"J Bras","year":"2012","unstructured":"Bras J, Guerreiro R, Hardy J (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci 13(7):453\u2013464. doi: 10.1038\/nrn3271","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"9390_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1101\/pdb.top067819","volume":"2012","author":"AV Smith","year":"2012","unstructured":"Smith AV (2012) Genetic analysis: moving between linkage and association. Cold Spring Harb Protoc 2012(2):174\u2013182. doi: 10.1101\/pdb.top067819","journal-title":"Cold Spring Harb Protoc"},{"key":"9390_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2164-13-356","volume":"13","author":"NJ Hudson","year":"2012","unstructured":"Hudson NJ, Dalrymple BP, Reverter A (2012) Beyond differential expression: the quest for causal mutations and effector molecules. BMC Genomics 13:356. doi: 10.1186\/1471-2164-13-356","journal-title":"BMC Genomics"},{"key":"9390_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fgene.2014.00369","volume":"5","author":"J Lord","year":"2014","unstructured":"Lord J, Lu AJ, Cruchaga C (2014) Identification of rare variants in Alzheimer\u2019s disease. Front Genet 5:369. doi: 10.3389\/fgene.2014.00369","journal-title":"Front Genet"},{"issue":"4","key":"9390_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s11684-012-0225-3","volume":"6","author":"Y Du","year":"2012","unstructured":"Du Y, Xie J, Chang W, Han Y, Cao G (2012) Genome-wide association studies: inherent limitations and future challenges. Front Med 6(4):444\u2013450. doi: 10.1007\/s11684-012-0225-3","journal-title":"Front Med"},{"issue":"2","key":"9390_CR19","first-page":"379","volume":"55","author":"M Boehnke","year":"1994","unstructured":"Boehnke M (1994) Limits of resolution of genetic linkage studies: implications for the positional cloning of human disease genes. Am J Hum Genet 55(2):379\u2013390","journal-title":"Am J Hum Genet"},{"issue":"5054","key":"9390_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185","journal-title":"Science"},{"issue":"1","key":"9390_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1755-5949.2010.00221.x","volume":"18","author":"HS Hoe","year":"2012","unstructured":"Hoe HS, Lee HK, Pak DT (2012) The upside of APP at synapses. CNS Neurosci Ther 18(1):47\u201356. doi: 10.1111\/j.1755-5949.2010.00221.x","journal-title":"CNS Neurosci Ther"},{"key":"9390_CR22","doi-asserted-by":"publisher","first-page":"246210","DOI":"10.6064\/2012\/246210","volume":"2012","author":"RC Barber","year":"2012","unstructured":"Barber RC (2012) The genetics of Alzheimer\u2019s disease. Scientifica (Cairo) 2012:246210. doi: 10.6064\/2012\/246210","journal-title":"Scientifica (Cairo)"},{"issue":"19","key":"9390_CR23","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1073\/pnas.85.19.7341","volume":"85","author":"DJ Selkoe","year":"1988","unstructured":"Selkoe DJ, Podlisny MB, Joachim CL, Vickers EA, Lee G, Fritz LC, Oltersdorf T (1988) Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A 85(19):7341\u20137345","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"9390_CR24","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.febslet.2013.05.010","volume":"587","author":"NN Nalivaeva","year":"2013","unstructured":"Nalivaeva NN, Turner AJ (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett 587(13):2046\u20132054. doi: 10.1016\/j.febslet.2013.05.010","journal-title":"FEBS Lett"},{"issue":"2","key":"9390_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/jnc.12239","volume":"126","author":"JN Octave","year":"2013","unstructured":"Octave JN, Pierrot N, Ferao Santos S, Nalivaeva NN, Turner AJ (2013) From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein. J Neurochem 126(2):183\u2013190. doi: 10.1111\/jnc.12239","journal-title":"J Neurochem"},{"issue":"3\u20134","key":"9390_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00221-011-2939-x","volume":"217","author":"CK Jung","year":"2012","unstructured":"Jung CK, Herms J (2012) Role of APP for dendritic spine formation and stability. Exp Brain Res 217(3\u20134):463\u2013470. doi: 10.1007\/s00221-011-2939-x","journal-title":"Exp Brain Res"},{"issue":"5","key":"9390_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.12675","volume":"129","author":"E Dawkins","year":"2014","unstructured":"Dawkins E, Small DH (2014) Insights into the physiological function of the beta-amyloid precursor protein: beyond Alzheimer\u2019s disease. J Neurochem 129(5):756\u2013769. doi: 10.1111\/jnc.12675","journal-title":"J Neurochem"},{"key":"9390_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1326-1-5","volume":"1","author":"H Zheng","year":"2006","unstructured":"Zheng H, Koo EH (2006) The amyloid precursor protein: beyond amyloid. Mol Neurodegener 1:5. doi: 10.1186\/1750-1326-1-5","journal-title":"Mol Neurodegener"},{"issue":"26","key":"9390_CR29","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","volume":"23","author":"JR Cirrito","year":"2003","unstructured":"Cirrito JR, May PC, O'Dell MA, Taylor JW, Parsadanian M, Cramer JW, Audia JE, Nissen JS et al (2003) In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23(26):8844\u20138853","journal-title":"J Neurosci"},{"issue":"7","key":"9390_CR30","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nm1438","volume":"12","author":"RJ Bateman","year":"2006","unstructured":"Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12(7):856\u2013861. doi: 10.1038\/nm1438","journal-title":"Nat Med"},{"issue":"2","key":"9390_CR31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81(2):741\u2013766","journal-title":"Physiol Rev"},{"issue":"Suppl 1","key":"9390_CR32","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1007\/s00259-007-0700-2","volume":"35","author":"A Nordberg","year":"2008","unstructured":"Nordberg A (2008) Amyloid plaque imaging in vivo: current achievement and future prospects. Eur J Nucl Med Mol Imaging 35(Suppl 1):S46\u2013S50. doi: 10.1007\/s00259-007-0700-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"9390_CR33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","volume":"46","author":"VL Villemagne","year":"2008","unstructured":"Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, Ackermann U, Cowie TF et al (2008) Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer\u2019s disease. Neuropsychologia 46(6):1688\u20131697. doi: 10.1016\/j.neuropsychologia.2008.02.008","journal-title":"Neuropsychologia"},{"issue":"4","key":"9390_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572\u2013580. doi: 10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"issue":"3","key":"9390_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.neuroscience.2007.10.054","volume":"151","author":"S Lesne","year":"2008","unstructured":"Lesne S, Kotilinek L, Ashe KH (2008) Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 151(3):745\u2013749. doi: 10.1016\/j.neuroscience.2007.10.054","journal-title":"Neuroscience"},{"issue":"3","key":"9390_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B (2012) The toxic Abeta oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci 15(3):349\u2013357. doi: 10.1038\/nn.3028","journal-title":"Nat Neurosci"},{"issue":"6","key":"9390_CR37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46(6):860\u2013866","journal-title":"Ann Neurol"},{"issue":"5","key":"9390_CR38","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","volume":"22","author":"MA Westerman","year":"2002","unstructured":"Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG et al (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci 22(5):1858\u20131867","journal-title":"J Neurosci"},{"issue":"5","key":"9390_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron 45(5):675\u2013688. doi: 10.1016\/j.neuron.2005.01.040","journal-title":"Neuron"},{"issue":"1\u20132","key":"9390_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2004.02.081","volume":"1012","author":"GW Arendash","year":"2004","unstructured":"Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF (2004) Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer\u2019s disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res 1012(1\u20132):29\u201341. doi: 10.1016\/j.brainres.2004.02.081","journal-title":"Brain Res"},{"issue":"1","key":"9390_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1073\/pnas.222681699","volume":"100","author":"G Bitan","year":"2003","unstructured":"Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 100(1):330\u2013335. doi: 10.1073\/pnas.222681699","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"9390_CR42","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1523\/JNEUROSCI.3537-10.2010","volume":"30","author":"B O'Nuallain","year":"2010","unstructured":"O'Nuallain B, Freir DB, Nicoll AJ, Risse E, Ferguson N, Herron CE, Collinge J, Walsh DM (2010) Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci 30(43):14411\u201314419. doi: 10.1523\/JNEUROSCI.3537-10.2010","journal-title":"J Neurosci"},{"issue":"46","key":"9390_CR43","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.1523\/JNEUROSCI.3916-08.2008","volume":"28","author":"LW Hung","year":"2008","unstructured":"Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD et al (2008) Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci 28(46):11950\u201311958. doi: 10.1523\/JNEUROSCI.3916-08.2008","journal-title":"J Neurosci"},{"key":"9390_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnagi.2013.00028","volume":"5","author":"KR Zahs","year":"2013","unstructured":"Zahs KR, Ashe KH (2013) beta-Amyloid oligomers in aging and Alzheimer\u2019s disease. Front Aging Neurosci 5:28. doi: 10.3389\/fnagi.2013.00028","journal-title":"Front Aging Neurosci"},{"issue":"7082","key":"9390_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352\u2013357. doi: 10.1038\/nature04533","journal-title":"Nature"},{"issue":"3","key":"9390_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.nbd.2012.03.005","volume":"46","author":"R Scherzer-Attali","year":"2012","unstructured":"Scherzer-Attali R, Farfara D, Cooper I, Levin A, Ben-Romano T, Trudler D, Vientrov M, Shaltiel-Karyo R et al (2012) Naphthoquinone-tryptophan reduces neurotoxic Abeta*56 levels and improves cognition in Alzheimer\u2019s disease animal model. Neurobiol Dis 46(3):663\u2013672. doi: 10.1016\/j.nbd.2012.03.005","journal-title":"Neurobiol Dis"},{"issue":"35","key":"9390_CR47","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A 106(35):14745\u201314750. doi: 10.1073\/pnas.0905127106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"9390_CR48","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2(7):a006338. doi: 10.1101\/cshperspect.a006338a006338","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 1","key":"9390_CR49","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.3233\/JAD-2012-129039","volume":"33","author":"WL Klein","year":"2013","unstructured":"Klein WL (2013) Synaptotoxic amyloid-beta oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer\u2019s disease? J Alzheimers Dis 33(Suppl 1):S49\u2013S65. doi: 10.3233\/JAD-2012-129039","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"9390_CR50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.mp.40015084001508","volume":"9","author":"J Gotz","year":"2004","unstructured":"Gotz J, Streffer JR, David D, Schild A, Hoerndli F, Pennanen L, Kurosinski P, Chen F (2004) Transgenic animal models of Alzheimer\u2019s disease and related disorders: histopathology, behavior and therapy. Mol Psychiatry 9(7):664\u2013683. doi: 10.1038\/sj.mp.40015084001508","journal-title":"Mol Psychiatry"},{"issue":"4","key":"9390_CR51","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.neurobiolaging.2011.05.003","volume":"33","author":"F Bao","year":"2012","unstructured":"Bao F, Wicklund L, Lacor PN, Klein WL, Nordberg A, Marutle A (2012) Different beta-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiol Aging 33(4):825. doi: 10.1016\/j.neurobiolaging.2011.05.003 , e821-813","journal-title":"Neurobiol Aging"},{"issue":"7","key":"9390_CR52","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/jnr.22640","volume":"89","author":"T Umeda","year":"2011","unstructured":"Umeda T, Tomiyama T, Sakama N, Tanaka S, Lambert MP, Klein WL, Mori H (2011) Intraneuronal amyloid beta oligomers cause cell death via endoplasmic reticulum stress, endosomal\/lysosomal leakage, and mitochondrial dysfunction in vivo. J Neurosci Res 89(7):1031\u20131042. doi: 10.1002\/jnr.22640","journal-title":"J Neurosci Res"},{"issue":"4","key":"9390_CR53","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neurobiolaging.2011.08.001","volume":"33","author":"G Amadoro","year":"2012","unstructured":"Amadoro G, Corsetti V, Atlante A, Florenzano F, Capsoni S, Bussani R, Mercanti D, Calissano P (2012) Interaction between NH(2)-tau fragment and Abeta in Alzheimer\u2019s disease mitochondria contributes to the synaptic deterioration. Neurobiol Aging 33(4):833. doi: 10.1016\/j.neurobiolaging.2011.08.001 , e831-825","journal-title":"Neurobiol Aging"},{"key":"9390_CR54","doi-asserted-by":"publisher","first-page":"162152","DOI":"10.1155\/2013\/162152","volume":"2013","author":"V Garcia-Escudero","year":"2013","unstructured":"Garcia-Escudero V, Martin-Maestro P, Perry G, Avila J (2013) Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid Med Cell Longev 2013:162152. doi: 10.1155\/2013\/162152","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"9390_CR55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1179\/016164105X49436","volume":"27","author":"D Watson","year":"2005","unstructured":"Watson D, Castano E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly ES Jr, Esh C et al (2005) Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer\u2019s disease. Neurol Res 27(8):869\u2013881. doi: 10.1179\/016164105X49436","journal-title":"Neurol Res"},{"issue":"1","key":"9390_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/exnr.1994.1107","volume":"128","author":"Y Goodman","year":"1994","unstructured":"Goodman Y, Mattson MP (1994) Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 128(1):1\u201312. doi: 10.1006\/exnr.1994.1107","journal-title":"Exp Neurol"},{"issue":"5","key":"9390_CR57","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.bbamcr.2010.10.005","volume":"1813","author":"S Camandola","year":"2011","unstructured":"Camandola S, Mattson MP (2011) Aberrant subcellular neuronal calcium regulation in aging and Alzheimer\u2019s disease. Biochim Biophys Acta 1813(5):965\u2013973. doi: 10.1016\/j.bbamcr.2010.10.005","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"9390_CR58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1471-4159.2001.00294.x","volume":"77","author":"D Bozyczko-Coyne","year":"2001","unstructured":"Bozyczko-Coyne D, O'Kane TM, Wu ZL, Dobrzanski P, Murthy S, Vaught JL, Scott RW (2001) CEP-1347\/KT-7515, an inhibitor of SAPK\/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. J Neurochem 77(3):849\u2013863","journal-title":"J Neurochem"},{"issue":"9","key":"9390_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024361PONE-D-11-11860","volume":"6","author":"M Tare","year":"2011","unstructured":"Tare M, Modi RM, Nainaparampil JJ, Puli OR, Bedi S, Fernandez-Funez P, Kango-Singh M, Singh A (2011) Activation of JNK signaling mediates amyloid-ss-dependent cell death. PLoS One 6(9), e24361. doi: 10.1371\/journal.pone.0024361PONE-D-11-11860","journal-title":"PLoS One"},{"issue":"10","key":"9390_CR60","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.neurobiolaging.2011.10.027","volume":"33","author":"G Dhawan","year":"2012","unstructured":"Dhawan G, Floden AM, Combs CK (2012) Amyloid-beta oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging 33(10):2247\u20132261. doi: 10.1016\/j.neurobiolaging.2011.10.027","journal-title":"Neurobiol Aging"},{"issue":"2","key":"9390_CR61","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.expneurol.2009.10.013","volume":"223","author":"JL Perez","year":"2010","unstructured":"Perez JL, Carrero I, Gonzalo P, Arevalo-Serrano J, Sanz-Anquela JM, Ortega J, Rodriguez M, Gonzalo-Ruiz A (2010) Soluble oligomeric forms of beta-amyloid (Abeta) peptide stimulate Abeta production via astrogliosis in the rat brain. Exp Neurol 223(2):410\u2013421. doi: 10.1016\/j.expneurol.2009.10.013","journal-title":"Exp Neurol"},{"issue":"3","key":"9390_CR62","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3233\/JAD-2010-101161","volume":"22","author":"PJ Ebenezer","year":"2010","unstructured":"Ebenezer PJ, Weidner AM, LeVine H 3rd, Markesbery WR, Murphy MP, Zhang L, Dasuri K, Fernandez-Kim SO et al (2010) Neuron specific toxicity of oligomeric amyloid-beta: role for JUN-kinase and oxidative stress. J Alzheimers Dis 22(3):839\u2013848. doi: 10.3233\/JAD-2010-101161","journal-title":"J Alzheimers Dis"},{"issue":"15","key":"9390_CR63","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M607483200","volume":"282","author":"FG Felice De","year":"2007","unstructured":"De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282(15):11590\u201311601. doi: 10.1074\/jbc.M607483200","journal-title":"J Biol Chem"},{"issue":"12","key":"9390_CR64","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","volume":"36","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review. Free Radic Res 36(12):1307\u20131313","journal-title":"Free Radic Res"},{"issue":"1","key":"9390_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085885PONE-D-13-37776","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Lu L, Jia J, Jia L, Geula C, Pei J, Xu Z, Qin W et al (2014) A lifespan observation of a novel mouse model: in vivo evidence supports abeta oligomer hypothesis. PLoS One 9(1), e85885. doi: 10.1371\/journal.pone.0085885PONE-D-13-37776","journal-title":"PLoS One"},{"issue":"14","key":"9390_CR66","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A 108(14):5819\u20135824. doi: 10.1073\/pnas.1017033108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9390_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H (2014) Oligomeric Abeta-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener 9(1):48. doi: 10.1186\/1750-1326-9-48","journal-title":"Mol Neurodegener"},{"key":"9390_CR68","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/978-3-7091-0932-8_25","volume":"970","author":"E Marcello","year":"2012","unstructured":"Marcello E, Epis R, Saraceno C, Di Luca M (2012) Synaptic dysfunction in Alzheimer\u2019s disease. Adv Exp Med Biol 970:573\u2013601. doi: 10.1007\/978-3-7091-0932-8_25","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"9390_CR69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010S0896627304006038","volume":"44","author":"DM Walsh","year":"2004","unstructured":"Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease. Neuron 44(1):181\u2013193. doi: 10.1016\/j.neuron.2004.09.010S0896627304006038","journal-title":"Neuron"},{"issue":"4","key":"9390_CR70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla FM, Oddo S (2005) Alzheimer\u2019s disease: Abeta, tau and synaptic dysfunction. Trends Mol Med 11(4):170\u2013176. doi: 10.1016\/j.molmed.2005.02.009","journal-title":"Trends Mol Med"},{"issue":"45","key":"9390_CR71","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1523\/JNEUROSCI.4305-10.2010","volume":"30","author":"SW Pimplikar","year":"2010","unstructured":"Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH (2010) Amyloid-independent mechanisms in Alzheimer\u2019s disease pathogenesis. J Neurosci 30(45):14946\u201314954. doi: 10.1523\/JNEUROSCI.4305-10.2010","journal-title":"J Neurosci"},{"issue":"3","key":"9390_CR72","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neurobiolaging.2010.05.022","volume":"32","author":"NK Robakis","year":"2011","unstructured":"Robakis NK (2011) Mechanisms of AD neurodegeneration may be independent of Abeta and its derivatives. Neurobiol Aging 32(3):372\u2013379. doi: 10.1016\/j.neurobiolaging.2010.05.022","journal-title":"Neurobiol Aging"},{"key":"9390_CR73","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/B978-0-12-386986-9.00011-9","volume":"102","author":"SD Skaper","year":"2012","unstructured":"Skaper SD (2012) Alzheimer\u2019s disease and amyloid: culprit or coincidence? Int Rev Neurobiol 102:277\u2013316. doi: 10.1016\/B978-0-12-386986-9.00011-9","journal-title":"Int Rev Neurobiol"},{"issue":"38","key":"9390_CR74","doi-asserted-by":"publisher","first-page":"15307","DOI":"10.1073\/pnas.1201632109","volume":"109","author":"J Bali","year":"2012","unstructured":"Bali J, Gheinani AH, Zurbriggen S, Rajendran L (2012) Role of genes linked to sporadic Alzheimer\u2019s disease risk in the production of beta-amyloid peptides. Proc Natl Acad Sci U S A 109(38):15307\u201315311. doi: 10.1073\/pnas.1201632109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6012","key":"9390_CR75","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330(6012):1774. doi: 10.1126\/science.1197623","journal-title":"Science"},{"issue":"3","key":"9390_CR76","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1471-4159.2011.07213.x","volume":"117","author":"K Sambamurti","year":"2011","unstructured":"Sambamurti K, Greig NH, Utsuki T, Barnwell EL, Sharma E, Mazell C, Bhat NR, Kindy MS et al (2011) Targets for AD treatment: conflicting messages from gamma-secretase inhibitors. J Neurochem 117(3):359\u2013374. doi: 10.1111\/j.1471-4159.2011.07213.x","journal-title":"J Neurochem"},{"issue":"111","key":"9390_CR77","doi-asserted-by":"publisher","first-page":"111cm133","DOI":"10.1126\/scitranslmed.3002609","volume":"3","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR Jr, Aisen PS (2011) Testing the right target and right drug at the right stage. Sci Transl Med 3(111):111cm133. doi: 10.1126\/scitranslmed.3002609","journal-title":"Sci Transl Med"},{"issue":"1","key":"9390_CR78","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/156720509787313871","volume":"6","author":"LS Schneider","year":"2009","unstructured":"Schneider LS, Lahiri DK (2009) The perils of Alzheimer's drug development. Curr Alzheimer Res 6(1):77\u201378","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"9390_CR79","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nm.2460","volume":"17","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe DJ (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17(9):1060\u20131065. doi: 10.1038\/nm.2460","journal-title":"Nat Med"},{"issue":"5","key":"9390_CR80","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1124\/mi.7.5.8","volume":"7","author":"GR Seabrook","year":"2007","unstructured":"Seabrook GR, Ray WJ, Shearman M, Hutton M (2007) Beyond amyloid: the next generation of Alzheimer\u2019s disease therapeutics. Mol Interv 7(5):261\u2013270. doi: 10.1124\/mi.7.5.8","journal-title":"Mol Interv"},{"issue":"5","key":"9390_CR81","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/ern.10.50","volume":"10","author":"T Town","year":"2010","unstructured":"Town T (2010) Alzheimer\u2019s disease beyond Abeta. Expert Rev Neurother 10(5):671\u2013675","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"9390_CR82","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/alzrt271","volume":"6","author":"K Nagga","year":"2014","unstructured":"Nagga K, Wattmo C, Zhang Y, Wahlund LO, Palmqvist S (2014) Cerebral inflammation is an underlying mechanism of early death in Alzheimer\u2019s disease: a 13-year cause-specific multivariate mortality study. Alzheimers Res Ther 6(4):41. doi: 10.1186\/alzrt271","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"9390_CR83","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","volume":"21","author":"D Pratico","year":"2001","unstructured":"Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21(12):4183\u20134187","journal-title":"J Neurosci"},{"issue":"6060","key":"9390_CR84","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1213210","volume":"334","author":"S Treusch","year":"2011","unstructured":"Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V, Shulman JM, Parrado A et al (2011) Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer\u2019s disease risk factors in yeast. Science 334(6060):1241\u20131245. doi: 10.1126\/science.1213210","journal-title":"Science"},{"issue":"2","key":"9390_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00401-012-1062-9","volume":"125","author":"M Pera","year":"2013","unstructured":"Pera M, Alcolea D, Sanchez-Valle R, Guardia-Laguarta C, Colom-Cadena M, Badiola N, Suarez-Calvet M, Llado A et al (2013) Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease. Acta Neuropathol 125(2):201\u2013213. doi: 10.1007\/s00401-012-1062-9","journal-title":"Acta Neuropathol"},{"issue":"10","key":"9390_CR86","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1073\/pnas.02056891010205689101","volume":"101","author":"R Li","year":"2004","unstructured":"Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L et al (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer\u2019s disease patients. Proc Natl Acad Sci U S A 101(10):3632\u20133637. doi: 10.1073\/pnas.02056891010205689101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"9390_CR87","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow EM (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30(36):11938\u201311950. doi: 10.1523\/JNEUROSCI.2357-10.2010","journal-title":"J Neurosci"},{"issue":"5","key":"9390_CR88","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","volume":"31","author":"OA Shipton","year":"2011","unstructured":"Shipton OA, Leitz JR, Dworzak J, Acton CE, Tunbridge EM, Denk F, Dawson HN, Vitek MP et al (2011) Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci 31(5):1688\u20131692. doi: 10.1523\/JNEUROSCI.2610-10.2011","journal-title":"J Neurosci"},{"issue":"9","key":"9390_CR89","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","volume":"29","author":"FG Felice De","year":"2008","unstructured":"De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J et al (2008) Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging 29(9):1334\u20131347. doi: 10.1016\/j.neurobiolaging.2007.02.029","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9390_CR90","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1042\/BST0380993","volume":"38","author":"FM LaFerla","year":"2010","unstructured":"LaFerla FM (2010) Pathways linking Abeta and tau pathologies. Biochem Soc Trans 38(4):993\u2013995. doi: 10.1042\/BST0380993","journal-title":"Biochem Soc Trans"},{"issue":"16","key":"9390_CR91","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1002\/jnr.22516","volume":"88","author":"Y Seino","year":"2010","unstructured":"Seino Y, Kawarabayashi T, Wakasaya Y, Watanabe M, Takamura A, Yamamoto-Watanabe Y, Kurata T, Abe K et al (2010) Amyloid beta accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model. J Neurosci Res 88(16):3547\u20133554. doi: 10.1002\/jnr.22516","journal-title":"J Neurosci Res"},{"issue":"3","key":"9390_CR92","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1074\/jbc.M507892200","volume":"281","author":"S Oddo","year":"2006","unstructured":"Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM (2006) Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 281(3):1599\u20131604. doi: 10.1074\/jbc.M507892200","journal-title":"J Biol Chem"},{"issue":"194","key":"9390_CR93","doi-asserted-by":"publisher","first-page":"194re192","DOI":"10.1126\/scitranslmed.3006446","volume":"5","author":"LF Maia","year":"2013","unstructured":"Maia LF, Kaeser SA, Reichwald J, Hruscha M, Martus P, Staufenbiel M, Jucker M (2013) Changes in amyloid-beta and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci Transl Med 5(194):194re192. doi: 10.1126\/scitranslmed.3006446","journal-title":"Sci Transl Med"},{"issue":"7","key":"9390_CR94","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijdevneu.2004.07.013","volume":"22","author":"J Gotz","year":"2004","unstructured":"Gotz J, Schild A, Hoerndli F, Pennanen L (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer\u2019s disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 22(7):453\u2013465. doi: 10.1016\/j.ijdevneu.2004.07.013","journal-title":"Int J Dev Neurosci"},{"issue":"7526","key":"9390_CR95","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D'Avanzo C, Chen H, Hooli B et al (2014) A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515(7526):274\u2013278. doi: 10.1038\/nature13800","journal-title":"Nature"},{"issue":"5580","key":"9390_CR96","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994297\/5580\/353","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. doi: 10.1126\/science.1072994297\/5580\/353","journal-title":"Science"},{"issue":"Suppl 1","key":"9390_CR97","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","volume":"33","author":"JZ Wang","year":"2013","unstructured":"Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K (2013) Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 33(Suppl 1):S123\u2013S139. doi: 10.3233\/JAD-2012-129031","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"9390_CR98","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71(4):505\u2013508. doi: 10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurol"},{"issue":"1","key":"9390_CR99","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Terro F (2013) Tau protein phosphatases in Alzheimer\u2019s disease: the leading role of PP2A. Ageing Res Rev 12(1):39\u201349. doi: 10.1016\/j.arr.2012.06.008","journal-title":"Ageing Res Rev"},{"key":"9390_CR100","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nbd.2013.09.010","volume":"62","author":"C Heraud","year":"2014","unstructured":"Heraud C, Goufak D, Ando K, Leroy K, Suain V, Yilmaz Z, De Decker R, Authelet M et al (2014) Increased misfolding and truncation of tau in APP\/PS1\/tau transgenic mice compared to mutant tau mice. Neurobiol Dis 62:100\u2013112. doi: 10.1016\/j.nbd.2013.09.010","journal-title":"Neurobiol Dis"},{"issue":"Pt A","key":"9390_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.018","volume":"76","author":"AM Pooler","year":"2014","unstructured":"Pooler AM, Noble W, Hanger DP, Pooler AM, Noble W, Hanger DP (2014) A role for tau at the synapse in Alzheimer\u2019s disease pathogenesis. Neuropharmacology 76(Pt A):1\u20138. doi: 10.1016\/j.neuropharm.2013.09.018","journal-title":"Neuropharmacology"},{"issue":"4","key":"9390_CR102","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G (2014) ApoE and Abeta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron 81(4):740\u2013754. doi: 10.1016\/j.neuron.2014.01.045","journal-title":"Neuron"},{"issue":"15","key":"9390_CR103","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 103(15):5644\u20135651. doi: 10.1073\/pnas.0600549103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9390_CR104","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/JMN:23:3:189","volume":"23","author":"Y Huang","year":"2004","unstructured":"Huang Y, Weisgraber KH, Mucke L, Mahley RW (2004) Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer\u2019s disease. J Mol Neurosci 23(3):189\u2013204. doi: 10.1385\/JMN:23:3:189","journal-title":"J Mol Neurosci"},{"key":"9390_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.08.025","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol Dis. doi: 10.1016\/j.nbd.2014.08.025","journal-title":"Neurobiol Dis"},{"issue":"2","key":"9390_CR106","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.410440226","volume":"44","author":"EM Reiman","year":"1998","unstructured":"Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A et al (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer\u2019s disease. Ann Neurol 44(2):288\u2013291. doi: 10.1002\/ana.410440226","journal-title":"Ann Neurol"},{"issue":"6","key":"9390_CR107","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1474-4422(07)70106-0","volume":"6","author":"P Shaw","year":"2007","unstructured":"Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, Clasen L, Evans A et al (2007) Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 6(6):494\u2013500. doi: 10.1016\/S1474-4422(07)70106-0","journal-title":"Lancet Neurol"},{"issue":"11","key":"9390_CR108","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1212\/01.WNL.0000129533.26544.BF","volume":"62","author":"RJ Caselli","year":"2004","unstructured":"Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG (2004) Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 62(11):1990\u20131995","journal-title":"Neurology"},{"issue":"9","key":"9390_CR109","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/archneur.64.9.1306","volume":"64","author":"RJ Caselli","year":"2007","unstructured":"Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE et al (2007) Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol 64(9):1306\u20131311. doi: 10.1001\/archneur.64.9.1306","journal-title":"Arch Neurol"},{"issue":"5","key":"9390_CR110","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10(5):333\u2013344. doi: 10.1038\/nrn2620","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"9390_CR111","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204\u20131222. doi: 10.1016\/j.cell.2012.02.040","journal-title":"Cell"},{"issue":"2","key":"9390_CR112","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","volume":"17","author":"T Arendt","year":"1997","unstructured":"Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer\u2019s disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17(2):516\u2013529","journal-title":"J Neurosci"},{"issue":"3","key":"9390_CR113","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1385\/JMN:23:3:167","volume":"23","author":"B Teter","year":"2004","unstructured":"Teter B (2004) ApoE-dependent plasticity in Alzheimer\u2019s disease. J Mol Neurosci 23(3):167\u2013179. doi: 10.1385\/JMN:23:3:167","journal-title":"J Mol Neurosci"},{"issue":"43","key":"9390_CR114","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D et al (2012) Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide. J Neurosci 32(43):15181\u201315192. doi: 10.1523\/JNEUROSCI.1542-12.2012","journal-title":"J Neurosci"},{"issue":"8","key":"9390_CR115","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","volume":"288","author":"LM Tai","year":"2013","unstructured":"Tai LM, Bilousova T, Jungbauer L, Roeske SK, Youmans KL, Yu C, Poon WW, Cornwell LB et al (2013) Levels of soluble apolipoprotein E\/amyloid-beta (Abeta) complex are reduced and oligomeric Abeta increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J Biol Chem 288(8):5914\u20135926. doi: 10.1074\/jbc.M112.442103","journal-title":"J Biol Chem"},{"issue":"5","key":"9390_CR116","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1096\/fj.10-175976","volume":"25","author":"E Cerf","year":"2011","unstructured":"Cerf E, Gustot A, Goormaghtigh E, Ruysschaert JM, Raussens V (2011) High ability of apolipoprotein E4 to stabilize amyloid-beta peptide oligomers, the pathological entities responsible for Alzheimer\u2019s disease. FASEB J 25(5):1585\u20131595. doi: 10.1096\/fj.10-175976","journal-title":"FASEB J"},{"issue":"3","key":"9390_CR117","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 63(3):287\u2013303. doi: 10.1016\/j.neuron.2009.06.026","journal-title":"Neuron"},{"key":"9390_CR118","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2014.00121","volume":"6","author":"H Xu","year":"2014","unstructured":"Xu H, Finkelstein DI, Adlard PA (2014) Interactions of metals and apolipoprotein E in Alzheimer\u2019s disease. Front Aging Neurosci 6:121. doi: 10.3389\/fnagi.2014.00121","journal-title":"Front Aging Neurosci"},{"issue":"89","key":"9390_CR119","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3(89):89ra57. doi: 10.1126\/scitranslmed.3002156","journal-title":"Sci Transl Med"},{"issue":"5","key":"9390_CR120","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM et al (2011) Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10(5):424\u2013435. doi: 10.1016\/S1474-4422(11)70077-1","journal-title":"Lancet Neurol"},{"issue":"38","key":"9390_CR121","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269(38):23403\u201323406","journal-title":"J Biol Chem"},{"issue":"16","key":"9390_CR122","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","volume":"270","author":"MJ LaDu","year":"1995","unstructured":"LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem 270(16):9039\u20139042","journal-title":"J Biol Chem"},{"key":"9390_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.06.015","author":"DM Michaelson","year":"2014","unstructured":"Michaelson DM (2014) ApoE4: the most prevalent yet understudied risk factor for Alzheimer\u2019s disease. Alzheimers Dement. doi: 10.1016\/j.jalz.2014.06.015","journal-title":"Alzheimers Dement"},{"issue":"2","key":"9390_CR124","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","volume":"122","author":"Y Ji","year":"2003","unstructured":"Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T (2003) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients. Neuroscience 122(2):305\u2013315","journal-title":"Neuroscience"},{"issue":"3","key":"9390_CR125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","volume":"8","author":"R Egensperger","year":"1998","unstructured":"Egensperger R, Kosel S, von Eitzen U, Graeber MB (1998) Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol 8(3):439\u2013447","journal-title":"Brain Pathol"},{"issue":"12","key":"9390_CR126","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996) Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334(12):752\u2013758. doi: 10.1056\/NEJM199603213341202","journal-title":"N Engl J Med"},{"issue":"4","key":"9390_CR127","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","volume":"70","author":"BV Zlokovic","year":"2013","unstructured":"Zlokovic BV (2013) Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol 70(4):440\u2013444. doi: 10.1001\/jamaneurol.2013.2152","journal-title":"JAMA Neurol"},{"issue":"7399","key":"9390_CR128","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485(7399):512\u2013516. doi: 10.1038\/nature11087","journal-title":"Nature"},{"issue":"20","key":"9390_CR129","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","volume":"286","author":"K Nishitsuji","year":"2011","unstructured":"Nishitsuji K, Hosono T, Nakamura T, Bu G, Michikawa M (2011) Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood\u2013brain barrier model. J Biol Chem 286(20):17536\u201317542. doi: 10.1074\/jbc.M111.225532","journal-title":"J Biol Chem"},{"issue":"5","key":"9390_CR130","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","volume":"361","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Zhong N, Rutenber E, Weisgraber KH (2006) Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils. J Mol Biol 361(5):932\u2013944. doi: 10.1016\/j.jmb.2006.06.080","journal-title":"J Mol Biol"},{"issue":"29","key":"9390_CR131","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1021\/bi2006702","volume":"50","author":"K Garai","year":"2011","unstructured":"Garai K, Baban B, Frieden C (2011) Self-association and stability of the ApoE isoforms at low pH: implications for ApoE-lipid interactions. Biochemistry 50(29):6356\u20136364. doi: 10.1021\/bi2006702","journal-title":"Biochemistry"},{"issue":"6","key":"9390_CR132","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","volume":"16","author":"Y Huang","year":"2010","unstructured":"Huang Y (2010) Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer\u2019s disease. Trends Mol Med 16(6):287\u2013294. doi: 10.1016\/j.molmed.2010.04.004","journal-title":"Trends Mol Med"},{"issue":"7","key":"9390_CR133","doi-asserted-by":"publisher","first-page":"14908","DOI":"10.3390\/ijms140714908","volume":"14","author":"TT Rohn","year":"2013","unstructured":"Rohn TT (2013) Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer\u2019s disease. Int J Mol Sci 14(7):14908\u201314922. doi: 10.3390\/ijms140714908","journal-title":"Int J Mol Sci"},{"issue":"17","key":"9390_CR134","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM et al (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90(17):8098\u20138102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"9390_CR135","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","volume":"91","author":"WJ Strittmatter","year":"1994","unstructured":"Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M et al (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A 91(23):11183\u201311186","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9390_CR136","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1172\/JCI117407","volume":"94","author":"DA Sanan","year":"1994","unstructured":"Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T et al (1994) Apolipoprotein E associates with beta amyloid peptide of Alzheimer\u2019s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 94(2):860\u2013869. doi: 10.1172\/JCI117407","journal-title":"J Clin Invest"},{"key":"9390_CR137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249\u2013302","journal-title":"Adv Protein Chem"},{"issue":"19","key":"9390_CR138","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1073\/pnas.14343981001434398100","volume":"100","author":"FM Harris","year":"2003","unstructured":"Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, Fish JD, Masliah E et al (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A 100(19):10966\u201310971. doi: 10.1073\/pnas.14343981001434398100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"9390_CR139","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.200424\/10\/2527","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Dee Fish J, Wyss-Coray T et al (2004) Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 24(10):2527\u20132534. doi: 10.1523\/JNEUROSCI.4315-03.200424\/10\/2527","journal-title":"J Neurosci"},{"issue":"41","key":"9390_CR140","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling Y, Bien-Ly N, Xu Q, Li G, Bernardo A, Yoon SY, Zwilling D, Yan TX et al (2010) Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci 30(41):13707\u201313717. doi: 10.1523\/JNEUROSCI.4040-10.2010","journal-title":"J Neurosci"},{"issue":"1","key":"9390_CR141","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng0996-55","volume":"14","author":"M Miyata","year":"1996","unstructured":"Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14(1):55\u201361. doi: 10.1038\/ng0996-55","journal-title":"Nat Genet"},{"issue":"14","key":"9390_CR142","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/bi982437dbi982437d","volume":"38","author":"RD Moir","year":"1999","unstructured":"Moir RD, Atwood CS, Romano DM, Laurans MH, Huang X, Bush AI, Smith JD, Tanzi RE (1999) Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations. Biochemistry 38(14):4595\u20134603. doi: 10.1021\/bi982437dbi982437d","journal-title":"Biochemistry"},{"issue":"43","key":"9390_CR143","doi-asserted-by":"publisher","first-page":"44795","DOI":"10.1074\/jbc.M408127200M408127200","volume":"279","author":"FM Harris","year":"2004","unstructured":"Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y (2004) Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem 279(43):44795\u201344801. doi: 10.1074\/jbc.M408127200M408127200","journal-title":"J Biol Chem"},{"issue":"29","key":"9390_CR144","doi-asserted-by":"publisher","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara M, Sato N, Kurinami H, Takeuchi D, Takeda S, Shimamura M, Yamashita T, Uchiyama Y et al (2010) Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance. J Biol Chem 285(29):22091\u201322102. doi: 10.1074\/jbc.M110.102277","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"9390_CR145","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.neurobiolaging.2014.03.037","volume":"35","author":"J Poirier","year":"2014","unstructured":"Poirier J, Miron J, Picard C, Gormley P, Theroux L, Breitner J, Dea D (2014) Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer\u2019s disease. Neurobiol Aging 35(Suppl 2):S3\u2013S10. doi: 10.1016\/j.neurobiolaging.2014.03.037","journal-title":"Neurobiol Aging"},{"issue":"2","key":"9390_CR146","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/156720507780362164","volume":"4","author":"DK Lahiri","year":"2007","unstructured":"Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH (2007) How and when environmental agents and dietary factors affect the course of Alzheimer\u2019s disease: the \u201cLEARn\u201d model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 4(2):219\u2013228","journal-title":"Curr Alzheimer Res"},{"key":"9390_CR147","doi-asserted-by":"publisher","first-page":"369808","DOI":"10.1155\/2012\/369808","volume":"2012","author":"C Reitz","year":"2012","unstructured":"Reitz C (2012) Alzheimer\u2019s disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis 2012:369808. doi: 10.1155\/2012\/369808","journal-title":"Int J Alzheimers Dis"},{"issue":"4","key":"9390_CR148","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-9877(84)90154-3","volume":"15","author":"F Abalan","year":"1984","unstructured":"Abalan F (1984) Alzheimer\u2019s disease and malnutrition: a new etiological hypothesis. Med Hypotheses 15(4):385\u2013393","journal-title":"Med Hypotheses"},{"issue":"3","key":"9390_CR149","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0306-9877(89)90185-0","volume":"29","author":"SI Rapoport","year":"1989","unstructured":"Rapoport SI (1989) Hypothesis: Alzheimer\u2019s disease is a phylogenetic disease. Med Hypotheses 29(3):147\u2013150","journal-title":"Med Hypotheses"},{"issue":"4","key":"9390_CR150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0306-9877(90)90109-R","volume":"32","author":"VD Deshmukh","year":"1990","unstructured":"Deshmukh VD, Deshmukh SV (1990) Stress-adaptation failure hypothesis of Alzheimer\u2019s disease. Med Hypotheses 32(4):293\u2013295","journal-title":"Med Hypotheses"},{"issue":"10","key":"9390_CR151","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 12(10):383\u2013388","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"9390_CR152","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1357-4310(95)91532-X","volume":"1","author":"JN Davis","year":"1995","unstructured":"Davis JN, Hunnicutt EJ Jr, Chisholm JC (1995) A mitochondrial bottleneck hypothesis of Alzheimer\u2019s disease. Mol Med Today 1(5):240\u2013247","journal-title":"Mol Med Today"},{"issue":"1","key":"9390_CR153","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","volume":"63","author":"RH Swerdlow","year":"2004","unstructured":"Swerdlow RH, Khan SM (2004) A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease. Med Hypotheses 63(1):8\u201320. doi: 10.1016\/j.mehy.2003.12.045","journal-title":"Med Hypotheses"},{"issue":"8","key":"9390_CR154","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","volume":"1842","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH, Burns JM, Khan SM (2014) The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 1842(8):1219\u20131231. doi: 10.1016\/j.bbadis.2013.09.010","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9390_CR155","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12035-012-8307-4","volume":"46","author":"K Leuner","year":"2012","unstructured":"Leuner K, Muller WE, Reichert AS (2012) From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer\u2019s disease. Mol Neurobiol 46(1):186\u2013193. doi: 10.1007\/s12035-012-8307-4","journal-title":"Mol Neurobiol"},{"issue":"5","key":"9390_CR156","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02071314","volume":"15","author":"HB Pollard","year":"1995","unstructured":"Pollard HB, Arispe N, Rojas E (1995) Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity. Cell Mol Neurobiol 15(5):513\u2013526","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"9390_CR157","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0196-9781(02)00067-0","volume":"23","author":"BL Kagan","year":"2002","unstructured":"Kagan BL, Hirakura Y, Azimov R, Azimova R, Lin MC (2002) The channel hypothesis of Alzheimer\u2019s disease: current status. Peptides 23(7):1311\u20131315","journal-title":"Peptides"},{"issue":"3","key":"9390_CR158","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1515\/REVNEURO.1995.6.3.221","volume":"6","author":"TJ Marczynski","year":"1995","unstructured":"Marczynski TJ (1995) GABAergic deafferentation hypothesis of brain aging and Alzheimer\u2019s disease; pharmacologic profile of the benzodiazepine antagonist, flumazenil. Rev Neurosci 6(3):221\u2013258","journal-title":"Rev Neurosci"},{"issue":"5","key":"9390_CR159","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/brain.2014.0236","volume":"4","author":"MR Brier","year":"2014","unstructured":"Brier MR, Thomas JB, Ances BM (2014) Network dysfunction in Alzheimer\u2019s disease: refining the disconnection hypothesis. Brain Connect 4(5):299\u2013311. doi: 10.1089\/brain.2014.0236","journal-title":"Brain Connect"},{"issue":"5","key":"9390_CR160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0306-9877(96)90021-3","volume":"46","author":"W Ying","year":"1996","unstructured":"Ying W (1996) Deleterious network hypothesis of Alzheimer\u2019s disease. Med Hypotheses 46(5):421\u2013428","journal-title":"Med Hypotheses"},{"issue":"10","key":"9390_CR161","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/archneur.1997.00550220042012","volume":"54","author":"JW Olney","year":"1997","unstructured":"Olney JW, Wozniak DF, Farber NB (1997) Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch Neurol 54(10):1234\u20131240","journal-title":"Arch Neurol"},{"issue":"1","key":"9390_CR162","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"WR Markesbery","year":"1997","unstructured":"Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer\u2019s disease. Free Radic Biol Med 23(1):134\u2013147","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"9390_CR163","first-page":"401","volume":"25","author":"M Padurariu","year":"2013","unstructured":"Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R (2013) The oxidative stress hypothesis in Alzheimer\u2019s disease. Psychiatr Danub 25(4):401\u2013409","journal-title":"Psychiatr Danub"},{"issue":"12","key":"9390_CR164","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","volume":"29","author":"D Pratico","year":"2008","unstructured":"Pratico D (2008) Oxidative stress hypothesis in Alzheimer\u2019s disease: a reappraisal. Trends Pharmacol Sci 29(12):609\u2013615. doi: 10.1016\/j.tips.2008.09.001","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"9390_CR165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137\u2013147","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"9390_CR166","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2174\/092986706777935203","volume":"13","author":"K Sivaprakasam","year":"2006","unstructured":"Sivaprakasam K (2006) Towards a unifying hypothesis of Alzheimer\u2019s disease: cholinergic system linked to plaques, tangles and neuroinflammation. Curr Med Chem 13(18):2179\u20132188","journal-title":"Curr Med Chem"},{"issue":"3","key":"9390_CR167","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1020997903147","volume":"24","author":"SM Yatin","year":"1999","unstructured":"Yatin SM, Aksenov M, Butterfield DA (1999) The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer\u2019s disease. Neurochem Res 24(3):427\u2013435","journal-title":"Neurochem Res"},{"issue":"2","key":"9390_CR168","first-page":"127","volume":"19","author":"N Tabet","year":"2000","unstructured":"Tabet N, Mantle D, Orrell M (2000) Free radicals as mediators of toxicity in Alzheimer\u2019s disease: a review and hypothesis. Adverse Drug React Toxicol Rev 19(2):127\u2013152","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"11","key":"9390_CR169","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1023\/A:1020754807671","volume":"23","author":"R Subramaniam","year":"1998","unstructured":"Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J, Butterfield DA (1998) The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25\u201335) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer\u2019s disease. Neurochem Res 23(11):1403\u20131410","journal-title":"Neurochem Res"},{"issue":"1","key":"9390_CR170","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.21212","volume":"63","author":"NM Kemppainen","year":"2008","unstructured":"Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, Viitanen M, Parkkola R et al (2008) Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer\u2019s disease. Ann Neurol 63(1):112\u2013118. doi: 10.1002\/ana.21212","journal-title":"Ann Neurol"},{"issue":"3","key":"9390_CR171","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2990.2002.00385.x","volume":"28","author":"EH Bigio","year":"2002","unstructured":"Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL (2002) Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 28(3):218\u2013227","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"9390_CR172","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archneur.60.3.359","volume":"60","author":"N Scarmeas","year":"2003","unstructured":"Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell KL et al (2003) Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 60(3):359\u2013365","journal-title":"Arch Neurol"},{"issue":"2","key":"9390_CR173","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/13506120309041729","volume":"10","author":"NK Robakis","year":"2003","unstructured":"Robakis NK (2003) An Alzheimer\u2019s disease hypothesis based on transcriptional dysregulation. Amyloid 10(2):80\u201385","journal-title":"Amyloid"},{"issue":"4","key":"9390_CR174","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1474-4422(04)00707-0","volume":"3","author":"X Zhu","year":"2004","unstructured":"Zhu X, Raina AK, Perry G, Smith MA (2004) Alzheimer\u2019s disease: the two-hit hypothesis. Lancet Neurol 3(4):219\u2013226. doi: 10.1016\/S1474-4422(04)00707-0","journal-title":"Lancet Neurol"},{"issue":"3","key":"9390_CR175","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijom.2006.09.018","volume":"36","author":"N Furuta","year":"2007","unstructured":"Furuta N, Yoshioka I, Fukuizumi T, Tominaga K, Nishihara T, Fukuda J (2007) Morphological features of cartilage observed during mandibular distraction in rabbits. Int J Oral Maxillofac Surg 36(3):243\u2013249. doi: 10.1016\/j.ijom.2006.09.018","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"8","key":"9390_CR176","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nn0805-977","volume":"8","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE (2005) The synaptic Abeta hypothesis of Alzheimer disease. Nat Neurosci 8(8):977\u2013979. doi: 10.1038\/nn0805-977","journal-title":"Nat Neurosci"},{"issue":"1","key":"9390_CR177","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-004-0951-y","volume":"109","author":"K Iqbal","year":"2005","unstructured":"Iqbal K, Grundke-Iqbal I (2005) Metabolic\/signal transduction hypothesis of Alzheimer\u2019s disease and other tauopathies. Acta Neuropathol 109(1):25\u201331. doi: 10.1007\/s00401-004-0951-y","journal-title":"Acta Neuropathol"},{"issue":"2","key":"9390_CR178","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1073\/pnas.0608332104","volume":"104","author":"J Shen","year":"2007","unstructured":"Shen J, Kelleher RJ 3rd (2007) The presenilin hypothesis of Alzheimer\u2019s disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A 104(2):403\u2013409. doi: 10.1073\/pnas.0608332104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9390_CR179","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/156720507780362083","volume":"4","author":"PW Landfield","year":"2007","unstructured":"Landfield PW, Blalock EM, Chen KC, Porter NM (2007) A new glucocorticoid hypothesis of brain aging: implications for Alzheimer\u2019s disease. Curr Alzheimer Res 4(2):205\u2013212","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"9390_CR180","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbadis.2006.12.004","volume":"1772","author":"J Woods","year":"2007","unstructured":"Woods J, Snape M, Smith MA (2007) The cell cycle hypothesis of Alzheimer\u2019s disease: suggestions for drug development. Biochim Biophys Acta 1772(4):503\u2013508. doi: 10.1016\/j.bbadis.2006.12.004","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"9390_CR181","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","volume":"5","author":"AI Bush","year":"2008","unstructured":"Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer\u2019s disease based on the metal hypothesis. Neurotherapeutics 5(3):421\u2013432. doi: 10.1016\/j.nurt.2008.05.001","journal-title":"Neurotherapeutics"},{"issue":"2","key":"9390_CR182","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/JAD-2012-121231","volume":"33","author":"S Davenward","year":"2013","unstructured":"Davenward S, Bentham P, Wright J, Crome P, Job D, Polwart A, Exley C (2013) Silicon-rich mineral water as a non-invasive test of the \u2018aluminum hypothesis\u2019 in Alzheimer\u2019s disease. J Alzheimers Dis 33(2):423\u2013430. doi: 10.3233\/JAD-2012-121231","journal-title":"J Alzheimers Dis"},{"key":"9390_CR183","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/0-387-23226-5_11","volume":"38","author":"C Exley","year":"2005","unstructured":"Exley C (2005) The aluminium-amyloid cascade hypothesis and Alzheimer\u2019s disease. Subcell Biochem 38:225\u2013234","journal-title":"Subcell Biochem"},{"issue":"3","key":"9390_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033552","volume":"7","author":"TJ Craddock","year":"2012","unstructured":"Craddock TJ, Tuszynski JA, Chopra D, Casey N, Goldstein LE, Hameroff SR, Tanzi RE (2012) The zinc dyshomeostasis hypothesis of Alzheimer\u2019s disease. PLoS One 7(3), e33552. doi: 10.1371\/journal.pone.0033552","journal-title":"PLoS One"},{"issue":"3","key":"9390_CR185","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JAD-2011-111991","volume":"29","author":"R Squitti","year":"2012","unstructured":"Squitti R, Polimanti R (2012) Copper hypothesis in the missing hereditability of sporadic Alzheimer\u2019s disease: ATP7B gene as potential harbor of rare variants. J Alzheimers Dis 29(3):493\u2013501. doi: 10.3233\/JAD-2011-111991","journal-title":"J Alzheimers Dis"},{"key":"9390_CR186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1994.tb44398.x","volume":"747","author":"ZS Khachaturian","year":"1994","unstructured":"Khachaturian ZS (1994) Calcium hypothesis of Alzheimer\u2019s disease and brain aging. Ann N Y Acad Sci 747:1\u201311","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"9390_CR187","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1474-9726.2007.00295.x","volume":"6","author":"O Thibault","year":"2007","unstructured":"Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer\u2019s disease: minding the store. Aging Cell 6(3):307\u2013317. doi: 10.1111\/j.1474-9726.2007.00295.x","journal-title":"Aging Cell"},{"issue":"3","key":"9390_CR188","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00424-009-0736-1","volume":"459","author":"MJ Berridge","year":"2010","unstructured":"Berridge MJ (2010) Calcium hypothesis of Alzheimer\u2019s disease. Pflugers Arch 459(3):441\u2013449. doi: 10.1007\/s00424-009-0736-1","journal-title":"Pflugers Arch"},{"issue":"3","key":"9390_CR189","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12035-013-8428-4","volume":"48","author":"R Niranjan","year":"2013","unstructured":"Niranjan R (2013) Molecular basis of etiological implications in Alzheimer\u2019s disease: focus on neuroinflammation. Mol Neurobiol 48(3):412\u2013428. doi: 10.1007\/s12035-013-8428-4","journal-title":"Mol Neurobiol"},{"issue":"4","key":"9390_CR190","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jalz.2008.02.006","volume":"4","author":"SD Han","year":"2008","unstructured":"Han SD, Bondi MW (2008) Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 4(4):251\u2013254. doi: 10.1016\/j.jalz.2008.02.006","journal-title":"Alzheimers Dement"},{"key":"9390_CR191","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4614-4989-8_19","volume":"765","author":"HR Lucas","year":"2013","unstructured":"Lucas HR, Rifkind JM (2013) Considering the vascular hypothesis of Alzheimer\u2019s disease: effect of copper associated amyloid on red blood cells. Adv Exp Med Biol 765:131\u2013138. doi: 10.1007\/978-1-4614-4989-8_19","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"9390_CR192","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/jmedgenet-2012-101085","volume":"50","author":"A Alcina","year":"2013","unstructured":"Alcina A, Fedetz M, Fernandez O, Saiz A, Izquierdo G, Lucas M, Leyva L, Garcia-Leon JA et al (2013) Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis. J Med Genet 50(1):25\u201333. doi: 10.1136\/jmedgenet-2012-101085","journal-title":"J Med Genet"},{"issue":"1\u20133","key":"9390_CR193","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000285520","volume":"7","author":"JC Torre de la","year":"2010","unstructured":"de la Torre JC (2010) The vascular hypothesis of Alzheimer\u2019s disease: bench to bedside and beyond. Neurodegener Dis 7(1\u20133):116\u2013121. doi: 10.1159\/000285520","journal-title":"Neurodegener Dis"},{"issue":"3","key":"9390_CR194","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/gerona\/61.3.267","volume":"61","author":"JA Claassen","year":"2006","unstructured":"Claassen JA, Jansen RW (2006) Cholinergically mediated augmentation of cerebral perfusion in Alzheimer\u2019s disease and related cognitive disorders: the cholinergic-vascular hypothesis. J Gerontol A Biol Sci Med Sci 61(3):267\u2013271","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"9390_CR195","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28(4):202\u2013208. doi: 10.1016\/j.tins.2005.02.001","journal-title":"Trends Neurosci"},{"issue":"4","key":"9390_CR196","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"SA Small","year":"2008","unstructured":"Small SA, Duff K (2008) Linking Abeta and tau in late-onset Alzheimer\u2019s disease: a dual pathway hypothesis. Neuron 60(4):534\u2013542. doi: 10.1016\/j.neuron.2008.11.007","journal-title":"Neuron"},{"issue":"6","key":"9390_CR197","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104(6):1433\u20131439. doi: 10.1111\/j.1471-4159.2007.05194.x","journal-title":"J Neurochem"},{"issue":"50","key":"9390_CR198","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","volume":"30","author":"K Herrup","year":"2010","unstructured":"Herrup K (2010) Reimagining Alzheimer\u2019s disease\u2014an age-based hypothesis. J Neurosci 30(50):16755\u201316762. doi: 10.1523\/JNEUROSCI.4521-10.2010","journal-title":"J Neurosci"},{"key":"9390_CR199","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fphar.2014.00097","volume":"5","author":"R Piacentini","year":"2014","unstructured":"Piacentini R, De Chiara G, Li Puma DD, Ripoli C, Marcocci ME, Garaci E, Palamara AT, Grassi C (2014) HSV-1 and Alzheimer\u2019s disease: more than a hypothesis. Front Pharmacol 5:97. doi: 10.3389\/fphar.2014.00097","journal-title":"Front Pharmacol"},{"issue":"6","key":"9390_CR200","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/1073858410366162","volume":"16","author":"DW Ethell","year":"2010","unstructured":"Ethell DW (2010) An amyloid-notch hypothesis for Alzheimer\u2019s disease. Neuroscientist 16(6):614\u2013617. doi: 10.1177\/1073858410366162","journal-title":"Neuroscientist"},{"issue":"3","key":"9390_CR201","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","volume":"41","author":"RB Maccioni","year":"2010","unstructured":"Maccioni RB, Farias G, Morales I, Navarrete L (2010) The revitalized tau hypothesis on Alzheimer\u2019s disease. Arch Med Res 41(3):226\u2013231. doi: 10.1016\/j.arcmed.2010.03.007","journal-title":"Arch Med Res"},{"issue":"4","key":"9390_CR202","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","volume":"96","author":"ST Ferreira","year":"2011","unstructured":"Ferreira ST, Klein WL (2011) The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease. Neurobiol Learn Mem 96(4):529\u2013543. doi: 10.1016\/j.nlm.2011.08.003","journal-title":"Neurobiol Learn Mem"},{"key":"9390_CR203","doi-asserted-by":"publisher","first-page":"615829","DOI":"10.1155\/2011\/615829","volume":"2011","author":"VC Anderson","year":"2011","unstructured":"Anderson VC, Lenar DP, Quinn JF, Rooney WD (2011) The blood\u2013brain barrier and microvascular water exchange in Alzheimer\u2019s disease. Cardiovasc Psychiatry Neurol 2011:615829. doi: 10.1155\/2011\/615829","journal-title":"Cardiovasc Psychiatry Neurol"},{"issue":"1","key":"9390_CR204","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000329544000329544","volume":"1","author":"G Giaccone","year":"2011","unstructured":"Giaccone G, Orsi L, Cupidi C, Tagliavini F (2011) Lipofuscin hypothesis of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord Extra 1(1):292\u2013296. doi: 10.1159\/000329544000329544","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"9390_CR205","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1100\/2011\/625690","volume":"11","author":"YB Yurov","year":"2011","unstructured":"Yurov YB, Vorsanova SG, Iourov IY (2011) The DNA replication stress hypothesis of Alzheimer\u2019s disease. ScientificWorldJournal 11:2602\u20132612. doi: 10.1100\/2011\/625690","journal-title":"ScientificWorldJournal"},{"key":"9390_CR206","doi-asserted-by":"publisher","first-page":"752894","DOI":"10.1155\/2012\/752894","volume":"2012","author":"KE Funk","year":"2012","unstructured":"Funk KE, Kuret J (2012) Lysosomal fusion dysfunction as a unifying hypothesis for Alzheimer\u2019s disease pathology. Int J Alzheimers Dis 2012:752894. doi: 10.1155\/2012\/752894","journal-title":"Int J Alzheimers Dis"},{"issue":"4","key":"9390_CR207","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.neurobiolaging.2012.09.011","volume":"34","author":"L Ostergaard","year":"2013","unstructured":"Ostergaard L, Aamand R, Gutierrez-Jimenez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB et al (2013) The capillary dysfunction hypothesis of Alzheimer\u2019s disease. Neurobiol Aging 34(4):1018\u20131031. doi: 10.1016\/j.neurobiolaging.2012.09.011","journal-title":"Neurobiol Aging"},{"key":"9390_CR208","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainresbull.2013.12.004","volume":"103","author":"JN Cochran","year":"2014","unstructured":"Cochran JN, Hall AM, Roberson ED (2014) The dendritic hypothesis for Alzheimer\u2019s disease pathophysiology. Brain Res Bull 103:18\u201328. doi: 10.1016\/j.brainresbull.2013.12.004","journal-title":"Brain Res Bull"},{"issue":"4","key":"9390_CR209","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/jnc.12637","volume":"129","author":"WG Wood","year":"2014","unstructured":"Wood WG, Li L, Muller WE, Eckert GP (2014) Cholesterol as a causative factor in Alzheimer\u2019s disease: a debatable hypothesis. J Neurochem 129(4):559\u2013572. doi: 10.1111\/jnc.12637","journal-title":"J Neurochem"},{"issue":"9490","key":"9390_CR210","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0140-6736(05)67382-5","volume":"366","author":"M Dawn Teare","year":"2005","unstructured":"Dawn Teare M, Barrett JH (2005) Genetic linkage studies. Lancet 366(9490):1036\u20131044. doi: 10.1016\/S0140-6736(05)67382-5","journal-title":"Lancet"},{"issue":"3","key":"9390_CR211","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ng1195-241","volume":"11","author":"E Lander","year":"1995","unstructured":"Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11(3):241\u2013247. doi: 10.1038\/ng1195-241","journal-title":"Nat Genet"},{"key":"9390_CR212","doi-asserted-by":"publisher","unstructured":"Ertekin-Taner N (2007) Genetics of Alzheimer\u2019s disease: a centennial review. Neurol Clin 25(3):611\u2013667. doi: 10.1016\/j.ncl.2007.03.009 , v","DOI":"10.1016\/j.ncl.2007.03.009"},{"issue":"3","key":"9390_CR213","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","volume":"33","author":"RJ Guerreiro","year":"2012","unstructured":"Guerreiro RJ, Gustafson DR, Hardy J (2012) The genetic architecture of Alzheimer\u2019s disease: beyond APP, PSENs and APOE. Neurobiol Aging 33(3):437\u2013456. doi: 10.1016\/j.neurobiolaging.2010.03.025","journal-title":"Neurobiol Aging"},{"issue":"7","key":"9390_CR214","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.neurobiolaging.2009.03.013","volume":"30","author":"AW Butler","year":"2009","unstructured":"Butler AW, Ng MY, Hamshere ML, Forabosco P, Wroe R, Al-Chalabi A, Lewis CM, Powell JF (2009) Meta-analysis of linkage studies for Alzheimer\u2019s disease\u2014a web resource. Neurobiol Aging 30(7):1037\u20131047. doi: 10.1016\/j.neurobiolaging.2009.03.013","journal-title":"Neurobiol Aging"},{"issue":"11","key":"9390_CR215","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1001\/archneur.65.11.1518","volume":"65","author":"JH Lee","year":"2008","unstructured":"Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R (2008) Analyses of the National Institute on Aging Late-Onset Alzheimer\u2019s disease Family Study: implication of additional loci. Arch Neurol 65(11):1518\u20131526. doi: 10.1001\/archneur.65.11.1518","journal-title":"Arch Neurol"},{"key":"9390_CR216","doi-asserted-by":"crossref","unstructured":"Sillen A, Andrade J, Lilius L, Forsell C, Axelman K, Odeberg J, Winblad B, Graff C (2008) Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's disease. Eur J Hum Genet 16(2):202\u2013208","DOI":"10.1038\/sj.ejhg.5201946"},{"issue":"22","key":"9390_CR217","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/hmg\/ddm224","volume":"16","author":"ML Hamshere","year":"2007","unstructured":"Hamshere ML, Holmans PA, Avramopoulos D, Bassett SS, Blacker D, Bertram L, Wiener H, Rochberg N et al (2007) Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer\u2019s disease. Hum Mol Genet 16(22):2703\u20132712. doi: 10.1093\/hmg\/ddm224","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9390_CR218","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1086\/518720","volume":"81","author":"F Liu","year":"2007","unstructured":"Liu F, Arias-Vasquez A, Sleegers K, Aulchenko YS, Kayser M, Sanchez-Juan P, Feng BJ, Bertoli-Avella AM et al (2007) A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 81(1):17\u201331. doi: 10.1086\/518720","journal-title":"Am J Hum Genet"},{"issue":"11","key":"9390_CR219","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/archneur.63.11.1591","volume":"63","author":"JH Lee","year":"2006","unstructured":"Lee JH, Cheng R, Santana V, Williamson J, Lantigua R, Medrano M, Arriaga A, Stern Y et al (2006) Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease. Arch Neurol 63(11):1591\u20131598. doi: 10.1001\/archneur.63.11.1591","journal-title":"Arch Neurol"},{"issue":"5","key":"9390_CR220","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ajmg.b.30350","volume":"141B","author":"SS Bassett","year":"2006","unstructured":"Bassett SS, Avramopoulos D, Perry RT, Wiener H, Watson B Jr, Go RC, Fallin MD (2006) Further evidence of a maternal parent-of-origin effect on chromosome 10 in late-onset Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 141B(5):537\u2013540. doi: 10.1002\/ajmg.b.30350","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"9390_CR221","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.b.30114","volume":"135B","author":"P Holmans","year":"2005","unstructured":"Holmans P, Hamshere M, Hollingworth P, Rice F, Tunstall N, Jones S, Moore P, Wavrant DeVrieze F et al (2005) Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 135B(1):24\u201332. doi: 10.1002\/ajmg.b.30114","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"9390_CR222","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddg007","volume":"12","author":"D Blacker","year":"2003","unstructured":"Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS et al (2003) Results of a high-resolution genome screen of 437 Alzheimer\u2019s disease families. Hum Mol Genet 12(1):23\u201332","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9390_CR223","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1086\/379083","volume":"73","author":"WK Scott","year":"2003","unstructured":"Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, Roses AD, Saunders AM, Gilbert JR et al (2003) Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet 73(5):1041\u20131051. doi: 10.1086\/379083","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9390_CR224","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ajmg.10183","volume":"114","author":"A Myers","year":"2002","unstructured":"Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D et al (2002) Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 114(2):235\u2013244. doi: 10.1002\/ajmg.10183","journal-title":"Am J Med Genet"},{"issue":"4","key":"9390_CR225","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/339815","volume":"70","author":"YJ Li","year":"2002","unstructured":"Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP et al (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70(4):985\u2013993","journal-title":"Am J Hum Genet"},{"issue":"Pt 5","key":"9390_CR226","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1017\/S0003480001008776","volume":"65","author":"D Curtis","year":"2001","unstructured":"Curtis D, North BV, Sham PC (2001) A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer\u2019s disease. Ann Hum Genet 65(Pt 5):473\u2013481. doi: 10.1017\/S0003480001008776","journal-title":"Ann Hum Genet"},{"key":"9390_CR227","doi-asserted-by":"crossref","unstructured":"\u200bPericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, Kemmerer B, Hall JL, Saunders AM, Roses AD, Small GW, Scott WK, Conneally PM, Vance JM, Haines JL (2000) Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 35 (9-10):1343\u20131352.","DOI":"10.1016\/S0531-5565(00)00196-0"},{"issue":"1","key":"9390_CR228","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1086\/341034","volume":"71","author":"JM Olson","year":"2002","unstructured":"Olson JM, Goddard KA, Dudek DM (2002) A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet 71(1):154\u2013161. doi: 10.1086\/341034","journal-title":"Am J Hum Genet"},{"key":"9390_CR229","doi-asserted-by":"crossref","unstructured":"Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, Spurlock G, Norton N et al (1999) A full genome scan for late onset Alzheimer\u2019s disease. Hum Mol Genet 8(2):237\u2013245","DOI":"10.1093\/hmg\/8.2.237"},{"key":"9390_CR230","doi-asserted-by":"crossref","unstructured":"Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278 (15):1237\u20131241","DOI":"10.1001\/jama.1997.03550150041033"},{"issue":"5","key":"9390_CR231","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/gm452gm452","volume":"5","author":"JA Miller","year":"2013","unstructured":"Miller JA, Woltjer RL, Goodenbour JM, Horvath S, Geschwind DH (2013) Genes and pathways underlying regional and cell type changes in Alzheimer\u2019s disease. Genome Med 5(5):48. doi: 10.1186\/gm452gm452","journal-title":"Genome Med"},{"issue":"Pt 12","key":"9390_CR232","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/brain\/awq258","volume":"133","author":"K Bossers","year":"2010","unstructured":"Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J et al (2010) Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer\u2019s disease. Brain 133(Pt 12):3699\u20133723. doi: 10.1093\/brain\/awq258","journal-title":"Brain"},{"issue":"12","key":"9390_CR233","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.neurobiolaging.2010.04.019","volume":"32","author":"D Avramopoulos","year":"2011","unstructured":"Avramopoulos D, Szymanski M, Wang R, Bassett S (2011) Gene expression reveals overlap between normal aging and Alzheimer\u2019s disease genes. Neurobiol Aging 32(12):2319. doi: 10.1016\/j.neurobiolaging.2010.04.019 , e2327-2334","journal-title":"Neurobiol Aging"},{"issue":"6","key":"9390_CR234","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jnr.22290","volume":"88","author":"MG Tan","year":"2010","unstructured":"Tan MG, Chua WT, Esiri MM, Smith AD, Vinters HV, Lai MK (2010) Genome wide profiling of altered gene expression in the neocortex of Alzheimer\u2019s disease. J Neurosci Res 88(6):1157\u20131169. doi: 10.1002\/jnr.22290","journal-title":"J Neurosci Res"},{"issue":"4","key":"9390_CR235","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neurobiolaging.2008.05.013","volume":"31","author":"WS Liang","year":"2010","unstructured":"Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA et al (2010) Neuronal gene expression in non-demented individuals with intermediate Alzheimer\u2019s disease neuropathology. Neurobiol Aging 31(4):549\u2013566. doi: 10.1016\/j.neurobiolaging.2008.05.013","journal-title":"Neurobiol Aging"},{"issue":"2","key":"9390_CR236","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008898","volume":"5","author":"J Nunez-Iglesias","year":"2010","unstructured":"Nunez-Iglesias J, Liu CC, Morgan TE, Finch CE, Zhou XJ (2010) Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease cortex reveals altered miRNA regulation. PLoS One 5(2), e8898. doi: 10.1371\/journal.pone.0008898","journal-title":"PLoS One"},{"issue":"10","key":"9390_CR237","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopsych.2010.05.030","volume":"68","author":"SD Ginsberg","year":"2010","unstructured":"Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV et al (2010) Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer\u2019s disease progression. Biol Psychiatry 68(10):885\u2013893. doi: 10.1016\/j.biopsych.2010.05.030","journal-title":"Biol Psychiatry"},{"issue":"10","key":"9390_CR238","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007642","volume":"4","author":"P Katsel","year":"2009","unstructured":"Katsel P, Tan W, Haroutunian V (2009) Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. PLoS One 4(10), e7642. doi: 10.1371\/journal.pone.0007642","journal-title":"PLoS One"},{"issue":"8","key":"9390_CR239","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006826","volume":"4","author":"IF Bronner","year":"2009","unstructured":"Bronner IF, Bochdanovits Z, Rizzu P, Kamphorst W, Ravid R, van Swieten JC, Heutink P (2009) Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways. PLoS One 4(8), e6826. doi: 10.1371\/journal.pone.0006826","journal-title":"PLoS One"},{"issue":"3","key":"9390_CR240","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004936","volume":"4","author":"C Williams","year":"2009","unstructured":"Williams C, Mehrian Shai R, Wu Y, Hsu YH, Sitzer T, Spann B, McCleary C, Mo Y et al (2009) Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer\u2019s disease. PLoS One 4(3), e4936. doi: 10.1371\/journal.pone.0004936","journal-title":"PLoS One"},{"issue":"3","key":"9390_CR241","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archneurol.2008.588","volume":"66","author":"W Qin","year":"2009","unstructured":"Qin W, Haroutunian V, Katsel P, Cardozo CP, Ho L, Buxbaum JD, Pasinetti GM (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 66(3):352\u2013361. doi: 10.1001\/archneurol.2008.588","journal-title":"Arch Neurol"},{"issue":"2","key":"9390_CR242","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1152\/physiolgenomics.00242.2007","volume":"33","author":"WS Liang","year":"2008","unstructured":"Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA et al (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer\u2019s disease: a reference data set. Physiol Genomics 33(2):240\u2013256. doi: 10.1152\/physiolgenomics.00242.2007","journal-title":"Physiol Genomics"},{"issue":"4","key":"9390_CR243","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurobiolaging.2006.11.008","volume":"29","author":"B Wilmot","year":"2008","unstructured":"Wilmot B, McWeeney SK, Nixon RR, Montine TJ, Laut J, Harrington CA, Kaye JA, Kramer PL (2008) Translational gene mapping of cognitive decline. Neurobiol Aging 29(4):524\u2013541. doi: 10.1016\/j.neurobiolaging.2006.11.008","journal-title":"Neurobiol Aging"},{"issue":"4\u20135","key":"9390_CR244","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","volume":"32","author":"P Katsel","year":"2007","unstructured":"Katsel P, Li C, Haroutunian V (2007) Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease? Neurochem Res 32(4\u20135):845\u2013856. doi: 10.1007\/s11064-007-9297-x","journal-title":"Neurochem Res"},{"issue":"4","key":"9390_CR245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2007-12402","volume":"12","author":"E Grunblatt","year":"2007","unstructured":"Grunblatt E, Zander N, Bartl J, Jie L, Monoranu CM, Arzberger T, Ravid R, Roggendorf W et al (2007) Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease. J Alzheimers Dis 12(4):291\u2013311","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"9390_CR246","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.yexcr.2006.10.028","volume":"313","author":"AT Weeraratna","year":"2007","unstructured":"Weeraratna AT, Kalehua A, Deleon I, Bertak D, Maher G, Wade MS, Lustig A, Becker KG et al (2007) Alterations in immunological and neurological gene expression patterns in Alzheimer\u2019s disease tissues. Exp Cell Res 313(3):450\u2013461. doi: 10.1016\/j.yexcr.2006.10.028","journal-title":"Exp Cell Res"},{"issue":"1","key":"9390_CR247","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2006.09.106","volume":"1127","author":"WM Brooks","year":"2007","unstructured":"Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, Faull RL, Starkey MP (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer\u2019s disease. Brain Res 1127(1):127\u2013135. doi: 10.1016\/j.brainres.2006.09.106","journal-title":"Brain Res"},{"issue":"2","key":"9390_CR248","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/WNR.0b013e32801198bc00001756-200701220-00003","volume":"18","author":"JG Cui","year":"2007","unstructured":"Cui JG, Hill JM, Zhao Y, Lukiw WJ (2007) Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer\u2019s disease. Neuroreport 18(2):115\u2013119. doi: 10.1097\/WNR.0b013e32801198bc00001756-200701220-00003","journal-title":"Neuroreport"},{"issue":"12","key":"9390_CR249","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2006.08.014","volume":"28","author":"A Parachikova","year":"2007","unstructured":"Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW (2007) Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 28(12):1821\u20131833. doi: 10.1016\/j.neurobiolaging.2006.08.014","journal-title":"Neurobiol Aging"},{"issue":"3","key":"9390_CR250","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.nbd.2005.09.004","volume":"21","author":"L Emilsson","year":"2006","unstructured":"Emilsson L, Saetre P, Jazin E (2006) Alzheimer\u2019s disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis 21(3):618\u2013625. doi: 10.1016\/j.nbd.2005.09.004","journal-title":"Neurobiol Dis"},{"issue":"10","key":"9390_CR251","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.neurobiolaging.2005.08.013","volume":"27","author":"T Dunckley","year":"2006","unstructured":"Dunckley T, Beach TG, Ramsey KE, Grover A, Mastroeni D, Walker DG, LaFleur BJ, Coon KD et al (2006) Gene expression correlates of neurofibrillary tangles in Alzheimer\u2019s disease. Neurobiol Aging 27(10):1359\u20131371. doi: 10.1016\/j.neurobiolaging.2005.08.013","journal-title":"Neurobiol Aging"},{"issue":"6","key":"9390_CR252","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ana.20667","volume":"58","author":"SA Small","year":"2005","unstructured":"Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, Honig L, Vonsattel JP et al (2005) Model-guided microarray implicates the retromer complex in Alzheimer\u2019s disease. Ann Neurol 58(6):909\u2013919. doi: 10.1002\/ana.20667","journal-title":"Ann Neurol"},{"issue":"6","key":"9390_CR253","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/15216540412331286002E5HKF394LYCEQBMW","volume":"56","author":"R Ricciarelli","year":"2004","unstructured":"Ricciarelli R, d'Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M (2004) Microarray analysis in Alzheimer\u2019s disease and normal aging. IUBMB Life 56(6):349\u2013354. doi: 10.1080\/15216540412331286002E5HKF394LYCEQBMW","journal-title":"IUBMB Life"},{"issue":"7","key":"9390_CR254","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.03085121000308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW (2004) Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101(7):2173\u20132178. doi: 10.1073\/pnas.03085121000308512100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9390_CR255","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.artmed.2004.01.008S093336570400020X","volume":"31","author":"PR Walker","year":"2004","unstructured":"Walker PR, Smith B, Liu QY, Famili AF, Valdes JJ, Liu Z, Lach B (2004) Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 31(2):137\u2013154. doi: 10.1016\/j.artmed.2004.01.008S093336570400020X","journal-title":"Artif Intell Med"},{"issue":"2","key":"9390_CR256","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0969-9961(02)00009-8","volume":"12","author":"PJ Yao","year":"2003","unstructured":"Yao PJ, Zhu M, Pyun EI, Brooks AI, Therianos S, Meyers VE, Coleman PD (2003) Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer\u2019s disease. Neurobiol Dis 12(2):97\u2013109","journal-title":"Neurobiol Dis"},{"issue":"3","key":"9390_CR257","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jnr.10351","volume":"70","author":"V Colangelo","year":"2002","unstructured":"Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70(3):462\u2013473. doi: 10.1002\/jnr.10351","journal-title":"J Neurosci Res"},{"issue":"11","key":"9390_CR258","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/10445490152717541","volume":"20","author":"JF Loring","year":"2001","unstructured":"Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R (2001) A gene expression profile of Alzheimer\u2019s disease. DNA Cell Biol 20(11):683\u2013695. doi: 10.1089\/10445490152717541","journal-title":"DNA Cell Biol"},{"issue":"2","key":"9390_CR259","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/bbrc.2001.4968S0006-291X(01)94968-X","volume":"284","author":"R Hata","year":"2001","unstructured":"Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, Yamamoto T, Okada H et al (2001) Up-regulation of calcineurin Abeta mRNA in the Alzheimer\u2019s disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 284(2):310\u2013316. doi: 10.1006\/bbrc.2001.4968S0006-291X(01)94968-X","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"9390_CR260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01753-5","volume":"298","author":"L Ho","year":"2001","unstructured":"Ho L, Guo Y, Spielman L, Petrescu O, Haroutunian V, Purohit D, Czernik A, Yemul S et al (2001) Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer\u2019s disease assessed by DNA microarray technique. Neurosci Lett 298(3):191\u2013194","journal-title":"Neurosci Lett"},{"issue":"1","key":"9390_CR261","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A","volume":"48","author":"SD Ginsberg","year":"2000","unstructured":"Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ (2000) Expression profile of transcripts in Alzheimer\u2019s disease tangle-bearing CA1 neurons. Ann Neurol 48(1):77\u201387","journal-title":"Ann Neurol"},{"issue":"3","key":"9390_CR262","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2990.2008.01003a.x","volume":"35","author":"CM Monoranu","year":"2009","unstructured":"Monoranu CM, Apfelbacher M, Grunblatt E, Puppe B, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K et al (2009) pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol 35(3):329\u2013337. doi: 10.1111\/j.1365-2990.2008.01003a.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1\u20132","key":"9390_CR263","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0169-328X(03)00337-1","volume":"118","author":"P Preece","year":"2003","unstructured":"Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118(1\u20132):60\u201371","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"9390_CR264","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/NEN.0b013e3181c7e32f","volume":"69","author":"PF Durrenberger","year":"2010","unstructured":"Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, Smith C, Walker R et al (2010) Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol 69(1):70\u201381. doi: 10.1097\/NEN.0b013e3181c7e32f","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"9390_CR265","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1471-4159.1992.tb10057.x","volume":"58","author":"BM Ross","year":"1992","unstructured":"Ross BM, Knowler JT, McCulloch J (1992) On the stability of messenger RNA and ribosomal RNA in the brains of control human subjects and patients with Alzheimer\u2019s disease. J Neurochem 58(5):1810\u20131819","journal-title":"J Neurochem"},{"issue":"4","key":"9390_CR266","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010153","volume":"5","author":"M Gomez Ravetti","year":"2010","unstructured":"Gomez Ravetti M, Rosso OA, Berretta R, Moscato P (2010) Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer\u2019s disease. PLoS One 5(4), e10153. doi: 10.1371\/journal.pone.0010153","journal-title":"PLoS One"},{"issue":"3","key":"9390_CR267","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/gepi.20297","volume":"32","author":"F Dudbridge","year":"2008","unstructured":"Dudbridge F, Gusnanto A (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32(3):227\u2013234. doi: 10.1002\/gepi.20297","journal-title":"Genet Epidemiol"},{"issue":"6","key":"9390_CR268","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/gepi.20331","volume":"32","author":"V Moskvina","year":"2008","unstructured":"Moskvina V, Schmidt KM (2008) On multiple-testing correction in genome-wide association studies. Genet Epidemiol 32(6):567\u2013573. doi: 10.1002\/gepi.20331","journal-title":"Genet Epidemiol"},{"issue":"5","key":"9390_CR269","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrg2344","volume":"9","author":"MI McCarthy","year":"2008","unstructured":"McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9(5):356\u2013369. doi: 10.1038\/nrg2344","journal-title":"Nat Rev Genet"},{"issue":"6","key":"9390_CR270","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-014-1282-2","volume":"127","author":"PT Nelson","year":"2014","unstructured":"Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX et al (2014) ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 127(6):825\u2013843. doi: 10.1007\/s00401-014-1282-2","journal-title":"Acta Neuropathol"},{"issue":"4","key":"9390_CR271","doi-asserted-by":"publisher","first-page":"e95413","DOI":"10.1371\/journal.pone.0095413","volume":"9","author":"E Perez-Palma","year":"2014","unstructured":"Perez-Palma E, Bustos BI, Villaman CF, Alarcon MA, Avila ME, Ugarte GD, Reyes AE, Opazo C et al (2014) Overrepresentation of glutamate signaling in Alzheimer\u2019s disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. PLoS One 9(4):e95413. doi: 10.1371\/journal.pone.0095413","journal-title":"PLoS One"},{"issue":"2","key":"9390_CR272","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","volume":"78","author":"C Cruchaga","year":"2013","unstructured":"Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT et al (2013) GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer\u2019s disease. Neuron 78(2):256\u2013268. doi: 10.1016\/j.neuron.2013.02.026","journal-title":"Neuron"},{"issue":"12","key":"9390_CR273","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45(12):1452\u20131458. doi: 10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"9390_CR274","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.86","author":"M Boada","year":"2013","unstructured":"Boada M, Antunez C, Ramirez-Lorca R, Destefano AL, Gonzalez-Perez A, Gayan J, Lopez-Arrieta J, Ikram MA et al (2013) ATP5H\/KCTD2 locus is associated with Alzheimer\u2019s disease risk. Mol Psychiatry. doi: 10.1038\/mp.2013.86","journal-title":"Mol Psychiatry"},{"issue":"14","key":"9390_CR275","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF et al (2013) Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4, and the risk of late-onset Alzheimer disease in African Americans. JAMA 309(14):1483\u20131492. doi: 10.1001\/jama.2013.2973","journal-title":"JAMA"},{"issue":"4","key":"9390_CR276","doi-asserted-by":"publisher","first-page":"e58618","DOI":"10.1371\/journal.pone.0058618 PONE-D-12-34104","volume":"8","author":"A Miyashita","year":"2013","unstructured":"Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, Kawarabayashi T, Shoji M et al (2013) SORL1 is genetically associated with late-onset Alzheimer\u2019s disease in Japanese, Koreans and Caucasians. PLoS One 8(4):e58618. doi: 10.1371\/journal.pone.0058618 PONE-D-12-34104","journal-title":"PLoS One"},{"key":"9390_CR277","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.45","volume":"2","author":"MI Kamboh","year":"2012","unstructured":"Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ et al (2012) Genome-wide association study of Alzheimer\u2019s disease. Transcult Psychiatry 2, e117. doi: 10.1038\/tp.2012.45","journal-title":"Transcult Psychiatry"},{"issue":"5","key":"9390_CR278","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1469-1809.2012.00721.x","volume":"76","author":"AC Cummings","year":"2012","unstructured":"Cummings AC, Jiang L, Velez Edwards DR, McCauley JL, Laux R, McFarland LL, Fuzzell D, Knebusch C et al (2012) Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene. Ann Hum Genet 76(5):342\u2013351. doi: 10.1111\/j.1469-1809.2012.00721.x","journal-title":"Ann Hum Genet"},{"issue":"12","key":"9390_CR279","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/archneurol.2011.646","volume":"68","author":"MW Logue","year":"2011","unstructured":"Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, Griffith P, Obisesan TO et al (2011) A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol 68(12):1569\u20131579. doi: 10.1001\/archneurol.2011.646","journal-title":"Arch Neurol"},{"issue":"3","key":"9390_CR280","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/archneurol.2010.292","volume":"68","author":"JH Lee","year":"2011","unstructured":"Lee JH, Cheng R, Barral S, Reitz C, Medrano M, Lantigua R, Jimenez-Velazquez IZ, Rogaeva E et al (2011) Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 68(3):320\u2013328. doi: 10.1001\/archneurol.2010.292","journal-title":"Arch Neurol"},{"issue":"5","key":"9390_CR281","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/gm249","volume":"3","author":"C Antunez","year":"2011","unstructured":"Antunez C, Boada M, Gonzalez-Perez A, Gayan J, Ramirez-Lorca R, Marin J, Hernandez I, Moreno-Rey C et al (2011) The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer\u2019s disease. Genome Med 3(5):33. doi: 10.1186\/gm249","journal-title":"Genome Med"},{"issue":"2","key":"9390_CR282","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001308","volume":"7","author":"EM Wijsman","year":"2011","unstructured":"Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, Lee JH, Bird TD et al (2011) Genome-wide association of familial late-onset Alzheimer\u2019s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 7(2), e1001308. doi: 10.1371\/journal.pgen.1001308","journal-title":"PLoS Genet"},{"issue":"2","key":"9390_CR283","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016616","volume":"6","author":"X Hu","year":"2011","unstructured":"Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E, Dechairo B, John S et al (2011) Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer\u2019s disease. PLoS One 6(2), e16616. doi: 10.1371\/journal.pone.0016616","journal-title":"PLoS One"},{"issue":"5","key":"9390_CR284","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML et al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43(5):429\u2013435. doi: 10.1038\/ng.803","journal-title":"Nat Genet"},{"issue":"5","key":"9390_CR285","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD et al (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43(5):436\u2013441. doi: 10.1038\/ng.801","journal-title":"Nat Genet"},{"issue":"1","key":"9390_CR286","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","volume":"76","author":"S Kim","year":"2011","unstructured":"Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ et al (2011) Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology 76(1):69\u201379. doi: 10.1212\/WNL.0b013e318204a397","journal-title":"Neurology"},{"issue":"9","key":"9390_CR287","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001130","volume":"6","author":"AC Naj","year":"2010","unstructured":"Naj AC, Beecham GW, Martin ER, Gallins PJ, Powell EH, Konidari I, Whitehead PL, Cai G et al (2010) Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLoS Genet 6(9), e1001130. doi: 10.1371\/journal.pgen.1001130","journal-title":"PLoS Genet"},{"issue":"18","key":"9390_CR288","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832\u20131840. doi: 10.1001\/jama.2010.574","journal-title":"JAMA"},{"issue":"8","key":"9390_CR289","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006501","volume":"4","author":"SG Potkin","year":"2009","unstructured":"Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A et al (2009) Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer\u2019s disease. PLoS One 4(8), e6501. doi: 10.1371\/journal.pone.0006501","journal-title":"PLoS One"},{"issue":"1","key":"9390_CR290","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/JAD-2010-1212","volume":"19","author":"EL Heinzen","year":"2010","unstructured":"Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, Strittmatter WJ, Burke JR, Hulette CM et al (2010) Genome-wide scan of copy number variation in late-onset Alzheimer\u2019s disease. J Alzheimers Dis 19(1):69\u201377. doi: 10.3233\/JAD-2010-1212","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"9390_CR291","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41(10):1094\u20131099. doi: 10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"9390_CR292","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093. doi: 10.1038\/ng.440","journal-title":"Nat Genet"},{"issue":"2","key":"9390_CR293","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ng.305","volume":"41","author":"MM Carrasquillo","year":"2009","unstructured":"Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS et al (2009) Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer\u2019s disease. Nat Genet 41(2):192\u2013198. doi: 10.1038\/ng.305","journal-title":"Nat Genet"},{"issue":"7","key":"9390_CR294","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/mp.2008.141","volume":"15","author":"TM Feulner","year":"2010","unstructured":"Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, Kuhn KA, Krawczak M et al (2010) Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 15(7):756\u2013766. doi: 10.1038\/mp.2008.141","journal-title":"Mol Psychiatry"},{"issue":"1","key":"9390_CR295","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ajmg.b.30767","volume":"150B","author":"SE Poduslo","year":"2009","unstructured":"Poduslo SE, Huang R, Huang J, Smith S (2009) Genome screen of late-onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis. Am J Med Genet B Neuropsychiatr Genet 150B(1):50\u201355. doi: 10.1002\/ajmg.b.30767","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"9390_CR296","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","volume":"84","author":"GW Beecham","year":"2009","unstructured":"Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet 84(1):35\u201343. doi: 10.1016\/j.ajhg.2008.12.008","journal-title":"Am J Hum Genet"},{"issue":"5","key":"9390_CR297","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B et al (2008) Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet 83(5):623\u2013632. doi: 10.1016\/j.ajhg.2008.10.008","journal-title":"Am J Hum Genet"},{"key":"9390_CR298","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1755-8794-1-44","volume":"1","author":"R Abraham","year":"2008","unstructured":"Abraham R, Moskvina V, Sims R, Hollingworth P, Morgan A, Georgieva L, Dowzell K, Cichon S et al (2008) A genome-wide association study for late-onset Alzheimer\u2019s disease using DNA pooling. BMC Med Genomics 1:44. doi: 10.1186\/1755-8794-1-44","journal-title":"BMC Med Genomics"},{"issue":"1","key":"9390_CR299","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archneurol.2007.3","volume":"65","author":"H Li","year":"2008","unstructured":"Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR et al (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65(1):45\u201353. doi: 10.1001\/archneurol.2007.3","journal-title":"Arch Neurol"},{"issue":"2","key":"9390_CR300","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000110789","volume":"5","author":"JA Webster","year":"2008","unstructured":"Webster JA, Myers AJ, Pearson JV, Craig DW, Hu-Lince D, Coon KD, Zismann VL, Beach T et al (2008) Sorl1 as an Alzheimer\u2019s disease predisposition gene? Neurodegener Dis 5(2):60\u201364. doi: 10.1159\/000110789","journal-title":"Neurodegener Dis"},{"issue":"5","key":"9390_CR301","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","volume":"54","author":"EM Reiman","year":"2007","unstructured":"Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV et al (2007) GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 54(5):713\u2013720. doi: 10.1016\/j.neuron.2007.05.022","journal-title":"Neuron"},{"issue":"4","key":"9390_CR302","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","volume":"68","author":"KD Coon","year":"2007","unstructured":"Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG et al (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer\u2019s disease. J Clin Psychiatry 68(4):613\u2013618","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"9390_CR303","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/ddm031","volume":"16","author":"A Grupe","year":"2007","unstructured":"Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R et al (2007) Evidence for novel susceptibility genes for late-onset Alzheimer\u2019s disease from a genome-wide association study of putative functional variants. Hum Mol Genet 16(8):865\u2013873. doi: 10.1093\/hmg\/ddm031","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9390_CR304","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","volume":"12","author":"K Bettens","year":"2013","unstructured":"Bettens K, Sleegers K, Van Broeckhoven C (2013) Genetic insights in Alzheimer\u2019s disease. Lancet Neurol 12(1):92\u2013104. doi: 10.1016\/S1474-4422(12)70259-4","journal-title":"Lancet Neurol"},{"key":"9390_CR305","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.23","author":"G Jun","year":"2015","unstructured":"Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS et al (2015) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. doi: 10.1038\/mp.2015.23","journal-title":"Mol Psychiatry"},{"issue":"2","key":"9390_CR306","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127. doi: 10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"issue":"2","key":"9390_CR307","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116. doi: 10.1056\/NEJMoa1211103","journal-title":"N Engl J Med"},{"issue":"6","key":"9390_CR308","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.neurobiolaging.2013.12.010","volume":"35","author":"BA Benitez","year":"2014","unstructured":"Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC et al (2014) Missense variant in TREML2 protects against Alzheimer\u2019s disease. Neurobiol Aging 35(6):1510. doi: 10.1016\/j.neurobiolaging.2013.12.010 , e1519-1526","journal-title":"Neurobiol Aging"},{"issue":"7484","key":"9390_CR309","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature12825","volume":"505","author":"C Cruchaga","year":"2014","unstructured":"Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J et al (2014) Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease. Nature 505(7484):550\u2013554. doi: 10.1038\/nature12825","journal-title":"Nature"},{"issue":"12","key":"9390_CR310","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/nm.3736","volume":"20","author":"MK Wetzel-Smith","year":"2014","unstructured":"Wetzel-Smith MK, Hunkapiller J, Bhangale TR, Srinivasan K, Maloney JA, Atwal JK, Sa SM, Yaylaoglu MB et al (2014) A rare mutation in UNC5C predisposes to late-onset Alzheimer\u2019s disease and increases neuronal cell death. Nat Med 20(12):1452\u20131457. doi: 10.1038\/nm.3736","journal-title":"Nat Med"},{"issue":"7409","key":"9390_CR311","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P et al (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488(7409):96\u201399. doi: 10.1038\/nature11283","journal-title":"Nature"},{"key":"9390_CR312","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1326-9-11","volume":"9","author":"CW Medway","year":"2014","unstructured":"Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, Pankratz S, Sando SB et al (2014) ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease. Mol Neurodegener 9:11. doi: 10.1186\/1750-1326-9-11","journal-title":"Mol Neurodegener"},{"issue":"2","key":"9390_CR313","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","volume":"31","author":"RJ Klose","year":"2006","unstructured":"Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31(2):89\u201397. doi: 10.1016\/j.tibs.2005.12.008","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"9390_CR314","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/cbic.201000195","volume":"12","author":"RZ Jurkowska","year":"2011","unstructured":"Jurkowska RZ, Jurkowski TP, Jeltsch A (2011) Structure and function of mammalian DNA methyltransferases. Chembiochem 12(2):206\u2013222. doi: 10.1002\/cbic.201000195","journal-title":"Chembiochem"},{"issue":"11\u201312","key":"9390_CR315","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.exger.2003.09.009","volume":"38","author":"D Bandyopadhyay","year":"2003","unstructured":"Bandyopadhyay D, Medrano EE (2003) The emerging role of epigenetics in cellular and organismal aging. Exp Gerontol 38(11\u201312):1299\u20131307","journal-title":"Exp Gerontol"},{"issue":"Suppl","key":"9390_CR316","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245\u2013254. doi: 10.1038\/ng1089ng1089","journal-title":"Nat Genet"},{"issue":"10","key":"9390_CR317","doi-asserted-by":"publisher","first-page":"E1106","DOI":"10.1073\/pnas.1420955112","volume":"112","author":"E Londin","year":"2015","unstructured":"Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y et al (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A 112(10):E1106\u2013E1115. doi: 10.1073\/pnas.1420955112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9390_CR318","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1399-0004.2011.01795.x","volume":"81","author":"ME Ketelaar","year":"2012","unstructured":"Ketelaar ME, Hofstra EM, Hayden MR (2012) What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration. Clin Genet 81(4):325\u2013333. doi: 10.1111\/j.1399-0004.2011.01795.x","journal-title":"Clin Genet"},{"issue":"5 Pt 2","key":"9390_CR319","doi-asserted-by":"publisher","first-page":"38R","DOI":"10.1203\/pdr.0b013e31803c7b98","volume":"61","author":"P Poulsen","year":"2007","unstructured":"Poulsen P, Esteller M, Vaag A, Fraga MF (2007) The epigenetic basis of twin discordance in age-related diseases. Pediatr Res 61(5 Pt 2):38R\u201342R. doi: 10.1203\/pdr.0b013e31803c7b98","journal-title":"Pediatr Res"},{"issue":"8","key":"9390_CR320","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ajmg.b.32201","volume":"162B","author":"K Lunnon","year":"2013","unstructured":"Lunnon K, Mill J (2013) Epigenetic studies in Alzheimer\u2019s disease: current findings, caveats, and considerations for future studies. Am J Med Genet B Neuropsychiatr Genet 162B(8):789\u2013799. doi: 10.1002\/ajmg.b.32201","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"7","key":"9390_CR321","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.neurobiolaging.2010.10.021","volume":"32","author":"J Mill","year":"2011","unstructured":"Mill J (2011) Toward an integrated genetic and epigenetic approach to Alzheimer\u2019s disease. Neurobiol Aging 32(7):1188\u20131191. doi: 10.1016\/j.neurobiolaging.2010.10.021","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9390_CR322","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","volume":"90","author":"L Chouliaras","year":"2010","unstructured":"Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F, van Os J, Steinbusch HW et al (2010) Epigenetic regulation in the pathophysiology of Alzheimer\u2019s disease. Prog Neurobiol 90(4):498\u2013510. doi: 10.1016\/j.pneurobio.2010.01.002","journal-title":"Prog Neurobiol"},{"issue":"7","key":"9390_CR323","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.neurobiolaging.2010.08.017","volume":"32","author":"D Mastroeni","year":"2011","unstructured":"Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J (2011) Epigenetic mechanisms in Alzheimer\u2019s disease. Neurobiol Aging 32(7):1161\u20131180. doi: 10.1016\/j.neurobiolaging.2010.08.017","journal-title":"Neurobiol Aging"},{"issue":"1","key":"9390_CR324","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.trsl.2014.05.006","volume":"165","author":"DA Bennett","year":"2015","unstructured":"Bennett DA, Yu L, Yang J, Srivastava GP, Aubin C, De Jager PL (2015) Epigenomics of Alzheimer\u2019s disease. Transl Res 165(1):200\u2013220. doi: 10.1016\/j.trsl.2014.05.006","journal-title":"Transl Res"},{"issue":"3","key":"9390_CR325","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/JAD-2012-111223","volume":"29","author":"KM Bakulski","year":"2012","unstructured":"Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, Albin RL, Hu H et al (2012) Genome-wide DNA methylation differences between late-onset Alzheimer\u2019s disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 29(3):571\u2013588. doi: 10.3233\/JAD-2012-111223","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"9390_CR326","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL Jager De","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, Eaton ML, Keenan BT et al (2014) Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17(9):1156\u20131163. doi: 10.1038\/nn.3786","journal-title":"Nat Neurosci"},{"issue":"9","key":"9390_CR327","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2013.02.021","volume":"34","author":"L Chouliaras","year":"2013","unstructured":"Chouliaras L, Mastroeni D, Delvaux E, Grover A, Kenis G, Hof PR, Steinbusch HW, Coleman PD et al (2013) Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer\u2019s disease patients. Neurobiol Aging 34(9):2091\u20132099. doi: 10.1016\/j.neurobiolaging.2013.02.021","journal-title":"Neurobiol Aging"},{"issue":"8","key":"9390_CR328","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006617","volume":"4","author":"D Mastroeni","year":"2009","unstructured":"Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD (2009) Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer\u2019s disease. PLoS One 4(8), e6617. doi: 10.1371\/journal.pone.0006617","journal-title":"PLoS One"},{"issue":"12","key":"9390_CR329","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.neurobiolaging.2008.12.005","volume":"31","author":"D Mastroeni","year":"2010","unstructured":"Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J (2010) Epigenetic changes in Alzheimer\u2019s disease: decrements in DNA methylation. Neurobiol Aging 31(12):2025\u20132037. doi: 10.1016\/j.neurobiolaging.2008.12.005","journal-title":"Neurobiol Aging"},{"issue":"10","key":"9390_CR330","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman MA, Lovell MA (2013) Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech Ageing Dev 134(10):486\u2013495. doi: 10.1016\/j.mad.2013.08.005","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"9390_CR331","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2013.11.031","volume":"35","author":"N Coppieters","year":"2014","unstructured":"Coppieters N, Dieriks BV, Lill C, Faull RL, Curtis MA, Dragunow M (2014) Global changes in DNA methylation and hydroxymethylation in Alzheimer\u2019s disease human brain. Neurobiol Aging 35(6):1334\u20131344. doi: 10.1016\/j.neurobiolaging.2013.11.031","journal-title":"Neurobiol Aging"},{"issue":"4","key":"9390_CR332","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/nan.12183","volume":"41","author":"T Lashley","year":"2015","unstructured":"Lashley T, Gami P, Valizadeh N, Li A, Revesz T, Balazs R (2015) Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 41(4):497\u2013506. doi: 10.1111\/nan.12183","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9390_CR333","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2014.11.002","volume":"45","author":"A Francesco Di","year":"2015","unstructured":"Di Francesco A, Arosio B, Falconi A, Micioni Di Bonaventura MV, Karimi M, Mari D, Casati M, Maccarrone M et al (2015) Global changes in DNA methylation in Alzheimer\u2019s disease peripheral blood mononuclear cells. Brain Behav Immun 45:139\u2013144. doi: 10.1016\/j.bbi.2014.11.002","journal-title":"Brain Behav Immun"},{"issue":"9","key":"9390_CR334","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, Troakes C, Al-Sarraj S et al (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci 17(9):1164\u20131170. doi: 10.1038\/nn.3782","journal-title":"Nat Neurosci"},{"issue":"4","key":"9390_CR335","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.neurobiolaging.2013.10.082","volume":"35","author":"DL Hove Van den","year":"2014","unstructured":"Van den Hove DL, Kompotis K, Lardenoije R, Kenis G, Mill J, Steinbusch HW, Lesch KP, Fitzsimons CP et al (2014) Epigenetically regulated microRNAs in Alzheimer\u2019s disease. Neurobiol Aging 35(4):731\u2013745. doi: 10.1016\/j.neurobiolaging.2013.10.082","journal-title":"Neurobiol Aging"},{"issue":"8","key":"9390_CR336","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/pmic.201200010","volume":"12","author":"K Zhang","year":"2012","unstructured":"Zhang K, Schrag M, Crofton A, Trivedi R, Vinters H, Kirsch W (2012) Targeted proteomics for quantification of histone acetylation in Alzheimer\u2019s disease. Proteomics 12(8):1261\u20131268. doi: 10.1002\/pmic.201200010","journal-title":"Proteomics"},{"issue":"4","key":"9390_CR337","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, Jiang T (2014) Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 40(4):1017\u20131027. doi: 10.3233\/JAD-132144","journal-title":"J Alzheimers Dis"},{"issue":"6868","key":"9390_CR338","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/415180a415180a","volume":"415","author":"Y Ho","year":"2002","unstructured":"Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, Millar A, Taylor P et al (2002) Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415(6868):180\u2013183. doi: 10.1038\/415180a415180a","journal-title":"Nature"},{"issue":"6868","key":"9390_CR339","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/415141a415141a","volume":"415","author":"AC Gavin","year":"2002","unstructured":"Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM et al (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415(6868):141\u2013147. doi: 10.1038\/415141a415141a","journal-title":"Nature"},{"issue":"8","key":"9390_CR340","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1073\/pnas.061034498061034498","volume":"98","author":"T Ito","year":"2001","unstructured":"Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A 98(8):4569\u20134574. doi: 10.1073\/pnas.061034498061034498","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6770","key":"9390_CR341","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/35001009","volume":"403","author":"P Uetz","year":"2000","unstructured":"Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V et al (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403(6770):623\u2013627. doi: 10.1038\/35001009","journal-title":"Nature"},{"issue":"Suppl 2","key":"9390_CR342","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-4-S2-S11","volume":"4","author":"ZP Liu","year":"2010","unstructured":"Liu ZP, Wang Y, Zhang XS, Chen L (2010) Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer\u2019s disease brains. BMC Syst Biol 4(Suppl 2):S11. doi: 10.1186\/1752-0509-4-S2-S11","journal-title":"BMC Syst Biol"},{"issue":"5","key":"9390_CR343","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1039\/c0mb00325e","volume":"7","author":"ZP Liu","year":"2011","unstructured":"Liu ZP, Wang Y, Zhang XS, Xia W, Chen L (2011) Detecting and analyzing differentially activated pathways in brain regions of Alzheimer\u2019s disease patients. Mol Biosyst 7(5):1441\u20131452. doi: 10.1039\/c0mb00325e","journal-title":"Mol Biosyst"},{"issue":"7","key":"9390_CR344","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040498PONE-D-11-13418","volume":"7","author":"D Liang","year":"2012","unstructured":"Liang D, Han G, Feng X, Sun J, Duan Y, Lei H (2012) Concerted perturbation observed in a hub network in Alzheimer\u2019s disease. PLoS One 7(7), e40498. doi: 10.1371\/journal.pone.0040498PONE-D-11-13418","journal-title":"PLoS One"},{"issue":"1\u20132","key":"9390_CR345","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/omi.2011.0054","volume":"16","author":"P Hallock","year":"2012","unstructured":"Hallock P, Thomas MA (2012) Integrating the Alzheimer\u2019s disease proteome and transcriptome: a comprehensive network model of a complex disease. OMICS 16(1\u20132):37\u201349. doi: 10.1089\/omi.2011.0054","journal-title":"OMICS"},{"issue":"Database issue","key":"9390_CR346","doi-asserted-by":"publisher","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TS Keshava Prasad","year":"2009","unstructured":"Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R et al (2009) Human Protein Reference Database\u20142009 update. Nucleic Acids Res 37(Database issue):D767\u2013D772. doi: 10.1093\/nar\/gkn892","journal-title":"Nucleic Acids Res"},{"key":"9390_CR347","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1752-0509-2-52","volume":"2","author":"J Goni","year":"2008","unstructured":"Goni J, Esteban FJ, de Mendizabal NV, Sepulcre J, Ardanza-Trevijano S, Agirrezabal I, Villoslada P (2008) A computational analysis of protein-protein interaction networks in neurodegenerative diseases. BMC Syst Biol 2:52. doi: 10.1186\/1752-0509-2-52","journal-title":"BMC Syst Biol"},{"key":"9390_CR348","unstructured":"Chen JY, Shen C, Sivachenko AY (2006) Mining Alzheimer disease relevant proteins from integrated protein interactome data. In: Pacific Symposium on Biocomputing11. pp 367\u2013378"},{"issue":"11","key":"9390_CR349","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076162PONE-D-13-31714","volume":"8","author":"M Kikuchi","year":"2013","unstructured":"Kikuchi M, Ogishima S, Miyamoto T, Miyashita A, Kuwano R, Nakaya J, Tanaka H (2013) Identification of unstable network modules reveals disease modules associated with the progression of Alzheimer\u2019s disease. PLoS One 8(11), e76162. doi: 10.1371\/journal.pone.0076162PONE-D-13-31714","journal-title":"PLoS One"},{"issue":"4","key":"9390_CR350","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1073\/pnas.0706851105","volume":"105","author":"M Rosvall","year":"2008","unstructured":"Rosvall M, Bergstrom CT (2008) Maps of random walks on complex networks reveal community structure. Proc Natl Acad Sci U S A 105(4):1118\u20131123. doi: 10.1073\/pnas.0706851105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9390_CR351","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/amiajnl-2011-000656","volume":"19","author":"K Regan","year":"2012","unstructured":"Regan K, Wang K, Doughty E, Li H, Li J, Lee Y, Kann MG, Lussier YA (2012) Translating Mendelian and complex inheritance of Alzheimer\u2019s disease genes for predicting unique personal genome variants. J Am Med Inform Assoc 19(2):306\u2013316. doi: 10.1136\/amiajnl-2011-000656","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"9390_CR352","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, Zhang C, Xie T et al (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153(3):707\u2013720. doi: 10.1016\/j.cell.2013.03.030","journal-title":"Cell"},{"key":"9390_CR353","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2164-15-199","volume":"15","author":"P Talwar","year":"2014","unstructured":"Talwar P, Silla Y, Grover S, Gupta M, Agarwal R, Kushwaha S, Kukreti R (2014) Genomic convergence and network analysis approach to identify candidate genes in Alzheimer\u2019s disease. BMC Genomics 15:199. doi: 10.1186\/1471-2164-15-199","journal-title":"BMC Genomics"},{"issue":"4","key":"9390_CR354","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/DMA-2010-0695","volume":"28","author":"JE McDermott","year":"2010","unstructured":"McDermott JE, Costa M, Janszen D, Singhal M, Tilton SC (2010) Separating the drivers from the driven: integrative network and pathway approaches aid identification of disease biomarkers from high-throughput data. Dis Markers 28(4):253\u2013266. doi: 10.3233\/DMA-2010-0695","journal-title":"Dis Markers"},{"issue":"6\u20137","key":"9390_CR355","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00335-007-9040-6","volume":"18","author":"SK Sieberts","year":"2007","unstructured":"Sieberts SK, Schadt EE (2007) Moving toward a system genetics view of disease. Mamm Genome 18(6\u20137):389\u2013401. doi: 10.1007\/s00335-007-9040-6","journal-title":"Mamm Genome"},{"issue":"Suppl 1","key":"9390_CR356","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2052.2006.01473.x","volume":"37","author":"EE Schadt","year":"2006","unstructured":"Schadt EE (2006) Novel integrative genomics strategies to identify genes for complex traits. Anim Genet 37(Suppl 1):18\u201323. doi: 10.1111\/j.1365-2052.2006.01473.x","journal-title":"Anim Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9390-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9390-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9390-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T15:10:14Z","timestamp":1653145814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9390-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":356,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9390"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9390-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,9]]}}}